1
|
Morgado BE, Sicardy B, Braga-Ribas F, Ortiz JL, Salo H, Vachier F, Desmars J, Pereira CL, Santos-Sanz P, Sfair R, de Santana T, Assafin M, Vieira-Martins R, Gomes-Júnior AR, Margoti G, Dhillon VS, Fernández-Valenzuela E, Broughton J, Bradshaw J, Langersek R, Benedetti-Rossi G, Souami D, Holler BJ, Kretlow M, Boufleur RC, Camargo JIB, Duffard R, Beisker W, Morales N, Lecacheux J, Rommel FL, Herald D, Benz W, Jehin E, Jankowsky F, Marsh TR, Littlefair SP, Bruno G, Pagano I, Brandeker A, Collier-Cameron A, Florén HG, Hara N, Olofsson G, Wilson TG, Benkhaldoun Z, Busuttil R, Burdanov A, Ferrais M, Gault D, Gillon M, Hanna W, Kerr S, Kolb U, Nosworthy P, Sebastian D, Snodgrass C, Teng JP, de Wit J. Author Correction: A dense ring of the trans-Neptunian object Quaoar outside its Roche limit. Nature 2024; 626:E2. [PMID: 38228877 DOI: 10.1038/s41586-024-07031-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2024]
Affiliation(s)
- B E Morgado
- Federal University of Rio de Janeiro - Observatory of Valongo, Rio de Janeiro, Brazil.
- National Observatory/MCTI, Rio de Janeiro, Brazil.
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil.
| | - B Sicardy
- LESIA, Observatory of Paris, University PSL, CNRS, UPMC, Sorbonne University, University of Paris Diderot, Sorbonne Paris City, Meudon, France
| | - F Braga-Ribas
- Federal University of Technology, Paraná (UTFPR/DAFIS), Curitiba, Brazil
| | - J L Ortiz
- Institute of Astrophysics at Andalucía, IAA-CSIC, Granada, Spain
| | - H Salo
- Space Physics and Astronomy Research unit, University of Oulu, Oulu, Finland
| | - F Vachier
- The Institute of Celestial Mechanics and Ephemeris Calculation (IMCCE), Observatory of Paris, PSL Research University, CNRS, Sorbonne University, UPMC University of Paris, University of Lille, Lille, France
| | - J Desmars
- The Institute of Celestial Mechanics and Ephemeris Calculation (IMCCE), Observatory of Paris, PSL Research University, CNRS, Sorbonne University, UPMC University of Paris, University of Lille, Lille, France
- Polytechnic Institute of Advanced Sciences (IPSA), Ivry-sur-Seine, France
| | - C L Pereira
- National Observatory/MCTI, Rio de Janeiro, Brazil
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
| | - P Santos-Sanz
- Institute of Astrophysics at Andalucía, IAA-CSIC, Granada, Spain
| | - R Sfair
- Institute for Astronomy and Astrophysics, Eberhard Karls University of Tübingen, Tübingen, Germany
- Orbital Dynamics and Planetology Group, UNESP - São Paulo State University, Guaratinguetá, Brazil
| | - T de Santana
- LESIA, Observatory of Paris, University PSL, CNRS, UPMC, Sorbonne University, University of Paris Diderot, Sorbonne Paris City, Meudon, France
- Orbital Dynamics and Planetology Group, UNESP - São Paulo State University, Guaratinguetá, Brazil
| | - M Assafin
- Federal University of Rio de Janeiro - Observatory of Valongo, Rio de Janeiro, Brazil
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
| | - R Vieira-Martins
- National Observatory/MCTI, Rio de Janeiro, Brazil
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
| | - A R Gomes-Júnior
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
- Orbital Dynamics and Planetology Group, UNESP - São Paulo State University, Guaratinguetá, Brazil
- Institute of Physics, Federal University of Uberlândia, Uberlândia, Brazil
| | - G Margoti
- Federal University of Technology, Paraná (UTFPR/DAFIS), Curitiba, Brazil
| | - V S Dhillon
- Department of Physics and Astronomy, University of Sheffield, Sheffield, UK
- Institute of Astrophysics of The Canary Islands, La Laguna, Spain
| | | | - J Broughton
- Reedy Creek Observatory, Gold Coast, Queensland, Australia
- Trans-Tasman Occultation Alliance (TTOA), Wellington, New Zealand
| | - J Bradshaw
- Samford Valley Observatory (Q79), Brisbane, Queensland, Australia
| | - R Langersek
- Algester Astronomical Observatory, Brisbane, Queensland, Australia
| | - G Benedetti-Rossi
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
- Orbital Dynamics and Planetology Group, UNESP - São Paulo State University, Guaratinguetá, Brazil
| | - D Souami
- LESIA, Observatory of Paris, University PSL, CNRS, UPMC, Sorbonne University, University of Paris Diderot, Sorbonne Paris City, Meudon, France
- Observatory of the Côte d'Azur, Lagrange Laboratory UMR7293 CNRS, Nice, France
- naXys, University of Namur, Namur, Belgium
| | - B J Holler
- Space Telescope Science Institute, Baltimore, MD, USA
| | - M Kretlow
- Institute of Astrophysics at Andalucía, IAA-CSIC, Granada, Spain
- International Occultation Timing Association / European Section, Hannover, Germany
- International Amateur Observatory e.V. (IAS), Mittenwalde, Germany
| | - R C Boufleur
- National Observatory/MCTI, Rio de Janeiro, Brazil
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
| | - J I B Camargo
- National Observatory/MCTI, Rio de Janeiro, Brazil
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
| | - R Duffard
- Institute of Astrophysics at Andalucía, IAA-CSIC, Granada, Spain
| | - W Beisker
- International Occultation Timing Association / European Section, Hannover, Germany
- International Amateur Observatory e.V. (IAS), Mittenwalde, Germany
| | - N Morales
- Institute of Astrophysics at Andalucía, IAA-CSIC, Granada, Spain
| | - J Lecacheux
- LESIA, Observatory of Paris, University PSL, CNRS, UPMC, Sorbonne University, University of Paris Diderot, Sorbonne Paris City, Meudon, France
| | - F L Rommel
- National Observatory/MCTI, Rio de Janeiro, Brazil
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
| | - D Herald
- Trans-Tasman Occultation Alliance (TTOA), Wellington, New Zealand
| | - W Benz
- Institute of Physics, University of Bern, Bern, Switzerland
- Center for Space and Habitability, University of Bern, Bern, Switzerland
| | - E Jehin
- STAR Institute, University of Liège, Liège, Belgium
| | - F Jankowsky
- Heidelberg-Königstuhl State Observatory, Heidelberg, Germany
| | - T R Marsh
- Department of Physics, University of Warwick, Coventry, UK
| | - S P Littlefair
- Department of Physics and Astronomy, University of Sheffield, Sheffield, UK
| | - G Bruno
- INAF, Catania Astrophysical Observatory, Catania, Italy
| | - I Pagano
- INAF, Catania Astrophysical Observatory, Catania, Italy
| | - A Brandeker
- Department of Astronomy, Stockholm University, AlbaNova University Center, Stockholm, Sweden
| | - A Collier-Cameron
- Centre for Exoplanet Science, SUPA School of Physics and Astronomy, University of St Andrews, North Haugh, St Andrews, UK
| | - H G Florén
- Department of Astronomy, Stockholm University, AlbaNova University Center, Stockholm, Sweden
| | - N Hara
- Astronomical Observatory at the University of Geneva, Versoix, Switzerland
| | - G Olofsson
- Department of Astronomy, Stockholm University, AlbaNova University Center, Stockholm, Sweden
| | - T G Wilson
- Centre for Exoplanet Science, SUPA School of Physics and Astronomy, University of St Andrews, North Haugh, St Andrews, UK
| | - Z Benkhaldoun
- Oukaimeden Observatory, High Energy Physics and Astrophysics Laboratory, FSSM, Cadi Ayyad University, Marrakech, Morocco
| | - R Busuttil
- School of Physical Sciences, The Open University, Walton Hall, Milton Keynes, UK
| | - A Burdanov
- Department of Earth, Atmospheric and Planetary Sciences, MIT, Cambridge, MA, USA
| | - M Ferrais
- Laboratory of Astrophysics of Marseille, University of Aix Marseille, CNRS, CNES, Marseille, France
| | - D Gault
- Trans-Tasman Occultation Alliance (TTOA), Wellington, New Zealand
| | - M Gillon
- Astrobiology Research Unit, University of Liège, Liège, Belgium
| | - W Hanna
- Trans-Tasman Occultation Alliance (TTOA), Wellington, New Zealand
| | - S Kerr
- Trans-Tasman Occultation Alliance (TTOA), Wellington, New Zealand
- Astronomical Association of Queensland, Pimpama, Queensland, Australia
| | - U Kolb
- School of Physical Sciences, The Open University, Walton Hall, Milton Keynes, UK
| | - P Nosworthy
- Trans-Tasman Occultation Alliance (TTOA), Wellington, New Zealand
| | - D Sebastian
- School of Physics and Astronomy, University of Birmingham, Birmingham, UK
| | - C Snodgrass
- Institute for Astronomy, University of Edinburgh, Royal Observatory, Edinburgh, UK
| | - J P Teng
- AGORA Observatory of Makes, AGORA, La Rivière, France
| | - J de Wit
- Department of Earth, Atmospheric and Planetary Sciences, MIT, Cambridge, MA, USA
| |
Collapse
|
2
|
Wilson TG, Harrel SK, Nunn ME. The Use of Enamel Matrix Derivative during Surgical Therapy for Peri-Implantitis: A Case Series. Dent J (Basel) 2023; 12:11. [PMID: 38248219 PMCID: PMC10814786 DOI: 10.3390/dj12010011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2023] [Revised: 12/15/2023] [Accepted: 12/21/2023] [Indexed: 01/23/2024] Open
Abstract
Peri-implantitis is a growing concern and currently, there is no agreement on the best method for treating this condition. This study looked at surgical intervention with the use of enamel matrix derivative (EMD) for treating this condition. A cohort of 25 (34 implants) consecutive patients treated with EMD for peri-implantitis was followed for up to 6.4 years. The survival of the implants as well as changes in clinical parameters are reported. Statistical analysis was performed using paired t tests and general estimating equations. The mean length of time implants were followed post-surgery was 3.05 ± 1.53 years. All but two of the treated implants survived in function (94%). Both failed implants were lost in the same patient, who was a heavy smoker. The changes in mean probing depth (1.94 ± 1.18 mm), change in deepest probing depth (3.12 ± 1.45 mm), and reduction in bleeding on probing (73.6 ± 43.9%) according to patient means were all highly significant (p < 0.001 for all changes). When EMD is used during surgical treatment of peri-implantitis, there is a high survival rate of implants and significant improvements in clinical parameters.
Collapse
Affiliation(s)
| | - Stephen K. Harrel
- College of Dentistry, Texas A&M University, 4510 Ridge Road, Dallas, TX 75229, USA
| | - Martha E. Nunn
- Private Practice Dentistry and Biostatistics, Omaha, NE 68178, USA;
| |
Collapse
|
3
|
Luque R, Osborn HP, Leleu A, Pallé E, Bonfanti A, Barragán O, Wilson TG, Broeg C, Cameron AC, Lendl M, Maxted PFL, Alibert Y, Gandolfi D, Delisle JB, Hooton MJ, Egger JA, Nowak G, Lafarga M, Rapetti D, Twicken JD, Morales JC, Carleo I, Orell-Miquel J, Adibekyan V, Alonso R, Alqasim A, Amado PJ, Anderson DR, Anglada-Escudé G, Bandy T, Bárczy T, Barrado Navascues D, Barros SCC, Baumjohann W, Bayliss D, Bean JL, Beck M, Beck T, Benz W, Billot N, Bonfils X, Borsato L, Boyle AW, Brandeker A, Bryant EM, Cabrera J, Carrazco-Gaxiola S, Charbonneau D, Charnoz S, Ciardi DR, Cochran WD, Collins KA, Crossfield IJM, Csizmadia S, Cubillos PE, Dai F, Davies MB, Deeg HJ, Deleuil M, Deline A, Delrez L, Demangeon ODS, Demory BO, Ehrenreich D, Erikson A, Esparza-Borges E, Falk B, Fortier A, Fossati L, Fridlund M, Fukui A, Garcia-Mejia J, Gill S, Gillon M, Goffo E, Gómez Maqueo Chew Y, Güdel M, Guenther EW, Günther MN, Hatzes AP, Helling C, Hesse KM, Howell SB, Hoyer S, Ikuta K, Isaak KG, Jenkins JM, Kagetani T, Kiss LL, Kodama T, Korth J, Lam KWF, Laskar J, Latham DW, Lecavelier des Etangs A, Leon JPD, Livingston JH, Magrin D, Matson RA, Matthews EC, Mordasini C, Mori M, Moyano M, Munari M, Murgas F, Narita N, Nascimbeni V, Olofsson G, Osborne HLM, Ottensamer R, Pagano I, Parviainen H, Peter G, Piotto G, Pollacco D, Queloz D, Quinn SN, Quirrenbach A, Ragazzoni R, Rando N, Ratti F, Rauer H, Redfield S, Ribas I, Ricker GR, Rudat A, Sabin L, Salmon S, Santos NC, Scandariato G, Schanche N, Schlieder JE, Seager S, Ségransan D, Shporer A, Simon AE, Smith AMS, Sousa SG, Stalport M, Szabó GM, Thomas N, Tuson A, Udry S, Vanderburg AM, Van Eylen V, Van Grootel V, Venturini J, Walter I, Walton NA, Watanabe N, Winn JN, Zingales T. A resonant sextuplet of sub-Neptunes transiting the bright star HD 110067. Nature 2023; 623:932-937. [PMID: 38030780 DOI: 10.1038/s41586-023-06692-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Accepted: 09/28/2023] [Indexed: 12/01/2023]
Abstract
Planets with radii between that of the Earth and Neptune (hereafter referred to as 'sub-Neptunes') are found in close-in orbits around more than half of all Sun-like stars1,2. However, their composition, formation and evolution remain poorly understood3. The study of multiplanetary systems offers an opportunity to investigate the outcomes of planet formation and evolution while controlling for initial conditions and environment. Those in resonance (with their orbital periods related by a ratio of small integers) are particularly valuable because they imply a system architecture practically unchanged since its birth. Here we present the observations of six transiting planets around the bright nearby star HD 110067. We find that the planets follow a chain of resonant orbits. A dynamical study of the innermost planet triplet allowed the prediction and later confirmation of the orbits of the rest of the planets in the system. The six planets are found to be sub-Neptunes with radii ranging from 1.94R⊕ to 2.85R⊕. Three of the planets have measured masses, yielding low bulk densities that suggest the presence of large hydrogen-dominated atmospheres.
Collapse
Affiliation(s)
- R Luque
- Department of Astronomy and Astrophysics, University of Chicago, Chicago, IL, USA.
| | - H P Osborn
- Space Research and Planetary Sciences, Physics Institute, University of Bern, Bern, Switzerland
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA, USA
- Kavli Institute for Astrophysics and Space Research, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - A Leleu
- Space Research and Planetary Sciences, Physics Institute, University of Bern, Bern, Switzerland
- Observatoire Astronomique de l'Université de Genève, Versoix, Switzerland
| | - E Pallé
- Instituto de Astrofisica de Canarias, La Laguna, Tenerife, Spain
- Departamento de Astrofisica, Universidad de La Laguna, La Laguna, Tenerife, Spain
| | - A Bonfanti
- Space Research Institute, Austrian Academy of Sciences, Graz, Austria
| | - O Barragán
- Sub-department of Astrophysics, Department of Physics, University of Oxford, Oxford, UK
| | - T G Wilson
- Centre for Exoplanet Science, SUPA School of Physics and Astronomy, University of St Andrews, St Andrews, UK
- Department of Physics, University of Warwick, Coventry, UK
- Centre for Exoplanets and Habitability, University of Warwick, Coventry, UK
| | - C Broeg
- Space Research and Planetary Sciences, Physics Institute, University of Bern, Bern, Switzerland
- Center for Space and Habitability, University of Bern, Bern, Switzerland
| | - A Collier Cameron
- Centre for Exoplanet Science, SUPA School of Physics and Astronomy, University of St Andrews, St Andrews, UK
| | - M Lendl
- Observatoire Astronomique de l'Université de Genève, Versoix, Switzerland
| | - P F L Maxted
- Astrophysics Group, Lennard Jones Building, Keele University, Keele, UK
| | - Y Alibert
- Space Research and Planetary Sciences, Physics Institute, University of Bern, Bern, Switzerland
- Center for Space and Habitability, University of Bern, Bern, Switzerland
| | - D Gandolfi
- Dipartimento di Fisica, Universita degli Studi di Torino, Torino, Italy
| | - J-B Delisle
- Observatoire Astronomique de l'Université de Genève, Versoix, Switzerland
| | - M J Hooton
- Cavendish Laboratory, University of Cambridge, Cambridge, UK
| | - J A Egger
- Space Research and Planetary Sciences, Physics Institute, University of Bern, Bern, Switzerland
| | - G Nowak
- Instituto de Astrofisica de Canarias, La Laguna, Tenerife, Spain
- Departamento de Astrofisica, Universidad de La Laguna, La Laguna, Tenerife, Spain
- Institute of Astronomy, Faculty of Physics, Astronomy and Informatics, Nicolaus Copernicus University, Toruń, Poland
| | - M Lafarga
- Department of Physics, University of Warwick, Coventry, UK
- Centre for Exoplanets and Habitability, University of Warwick, Coventry, UK
| | - D Rapetti
- NASA Ames Research Center, Moffett Field, CA, USA
- Research Institute for Advanced Computer Science, Universities Space Research Association, Washington, DC, USA
| | - J D Twicken
- NASA Ames Research Center, Moffett Field, CA, USA
- SETI Institute, Mountain View, CA, USA
| | - J C Morales
- Institut de Ciencies de l'Espai (ICE-CSIC), Bellaterra, Spain
- Institut d'Estudis Espacials de Catalunya (IEEC), Barcelona, Spain
| | - I Carleo
- Instituto de Astrofisica de Canarias, La Laguna, Tenerife, Spain
- INAF - Osservatorio Astrofisico di Torino, Pino Torinese, Italy
| | - J Orell-Miquel
- Instituto de Astrofisica de Canarias, La Laguna, Tenerife, Spain
- Departamento de Astrofisica, Universidad de La Laguna, La Laguna, Tenerife, Spain
| | - V Adibekyan
- Instituto de Astrofísica e Ciências do Espaço, Universidade do Porto, Porto, Portugal
- Departamento de Física e Astronomia, Faculdade de Ciências, Universidade do Porto, Porto, Portugal
| | - R Alonso
- Instituto de Astrofisica de Canarias, La Laguna, Tenerife, Spain
- Departamento de Astrofisica, Universidad de La Laguna, La Laguna, Tenerife, Spain
| | - A Alqasim
- Mullard Space Science Laboratory, University College London, Dorking, UK
| | - P J Amado
- Instituto de Astrofísica de Andalucía (IAA-CSIC), Granada, Spain
| | - D R Anderson
- Department of Physics, University of Warwick, Coventry, UK
- Centre for Exoplanets and Habitability, University of Warwick, Coventry, UK
| | - G Anglada-Escudé
- Institut de Ciencies de l'Espai (ICE-CSIC), Bellaterra, Spain
- Institut d'Estudis Espacials de Catalunya (IEEC), Barcelona, Spain
| | - T Bandy
- European Space Research and Technology Centre (ESTEC), European Space Agency (ESA), Noordwijk, The Netherlands
| | | | | | - S C C Barros
- Instituto de Astrofisica e Ciencias do Espaco, Universidade do Porto, Porto, Portugal
- Departamento de Fisica e Astronomia, Faculdade de Ciencias, Universidade do Porto, Porto, Portugal
| | - W Baumjohann
- Space Research Institute, Austrian Academy of Sciences, Graz, Austria
| | - D Bayliss
- Department of Physics, University of Warwick, Coventry, UK
| | - J L Bean
- Department of Astronomy and Astrophysics, University of Chicago, Chicago, IL, USA
| | - M Beck
- Observatoire Astronomique de l'Université de Genève, Versoix, Switzerland
| | - T Beck
- Space Research and Planetary Sciences, Physics Institute, University of Bern, Bern, Switzerland
| | - W Benz
- Space Research and Planetary Sciences, Physics Institute, University of Bern, Bern, Switzerland
- Center for Space and Habitability, University of Bern, Bern, Switzerland
| | - N Billot
- Observatoire Astronomique de l'Université de Genève, Versoix, Switzerland
| | - X Bonfils
- Université Grenoble Alpes, CNRS, IPAG, Grenoble, France
| | - L Borsato
- INAF - Osservatorio Astronomico di Padova, Padova, Italy
| | - A W Boyle
- Department of Astronomy, California Institute of Technology, Pasadena, CA, USA
| | - A Brandeker
- Department of Astronomy, Stockholm University, AlbaNova University Center, Stockholm, Sweden
| | - E M Bryant
- Department of Physics, University of Warwick, Coventry, UK
- Mullard Space Science Laboratory, University College London, Dorking, UK
| | - J Cabrera
- Institute of Planetary Research, German Aerospace Center (DLR), Berlin, Germany
| | - S Carrazco-Gaxiola
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Ciudad de México, Mexico
- Department of Physics and Astronomy, Georgia State University, Atlanta, GA, USA
- RECONS Institute, Chambersburg, PA, USA
| | - D Charbonneau
- Center for Astrophysics | Harvard & Smithsonian, Cambridge, MA, USA
| | - S Charnoz
- Université de Paris Cité, Institut de Physique du Globe de Paris, CNRS, Paris, France
| | - D R Ciardi
- Department of Astronomy, California Institute of Technology, Pasadena, CA, USA
| | - W D Cochran
- McDonald Observatory, The University of Texas, Austin, TX, USA
- Center for Planetary Systems Habitability, The University of Texas, Austin, TX, USA
| | - K A Collins
- Center for Astrophysics | Harvard & Smithsonian, Cambridge, MA, USA
| | - I J M Crossfield
- Department of Physics and Astronomy, University of Kansas, Lawrence, KS, USA
| | - Sz Csizmadia
- Institute of Planetary Research, German Aerospace Center (DLR), Berlin, Germany
| | - P E Cubillos
- Space Research Institute, Austrian Academy of Sciences, Graz, Austria
- INAF - Osservatorio Astrofisico di Torino, Pino Torinese, Italy
| | - F Dai
- Department of Astronomy, California Institute of Technology, Pasadena, CA, USA
- Division of Geological and Planetary Sciences, California Institute of Technology, Pasadena, CA, USA
| | - M B Davies
- Centre for Mathematical Sciences, Lund University, Lund, Sweden
| | - H J Deeg
- Instituto de Astrofisica de Canarias, La Laguna, Tenerife, Spain
- Departamento de Astrofisica, Universidad de La Laguna, La Laguna, Tenerife, Spain
| | - M Deleuil
- Aix Marseille Univ., CNRS, CNES, LAM, Marseille, France
| | - A Deline
- Observatoire Astronomique de l'Université de Genève, Versoix, Switzerland
| | - L Delrez
- Astrobiology Research Unit, Université de Liège, Liège, Belgium
- Space sciences, Technologies and Astrophysics Research (STAR) Institute, Université de Liège, Liège, Belgium
| | - O D S Demangeon
- Instituto de Astrofisica e Ciencias do Espaco, Universidade do Porto, Porto, Portugal
- Departamento de Fisica e Astronomia, Faculdade de Ciencias, Universidade do Porto, Porto, Portugal
| | - B-O Demory
- Space Research and Planetary Sciences, Physics Institute, University of Bern, Bern, Switzerland
- Center for Space and Habitability, University of Bern, Bern, Switzerland
| | - D Ehrenreich
- Observatoire Astronomique de l'Université de Genève, Versoix, Switzerland
- Centre Vie dans l'Univers, Faculté des sciences, Université de Genève, Genève 4, Switzerland
| | - A Erikson
- Institute of Planetary Research, German Aerospace Center (DLR), Berlin, Germany
| | - E Esparza-Borges
- Instituto de Astrofisica de Canarias, La Laguna, Tenerife, Spain
- Departamento de Astrofisica, Universidad de La Laguna, La Laguna, Tenerife, Spain
| | - B Falk
- Space Telescope Science Institute, Baltimore, MD, USA
| | - A Fortier
- Space Research and Planetary Sciences, Physics Institute, University of Bern, Bern, Switzerland
- Center for Space and Habitability, University of Bern, Bern, Switzerland
| | - L Fossati
- Space Research Institute, Austrian Academy of Sciences, Graz, Austria
| | - M Fridlund
- Leiden Observatory, University of Leiden, Leiden, The Netherlands
- Onsala Space Observatory, Department of Space, Earth and Environment, Chalmers University of Technology, Onsala, Sweden
| | - A Fukui
- Instituto de Astrofisica de Canarias, La Laguna, Tenerife, Spain
- Komaba Institute for Science, The University of Tokyo, Tokyo, Japan
| | - J Garcia-Mejia
- Center for Astrophysics | Harvard & Smithsonian, Cambridge, MA, USA
| | - S Gill
- Department of Physics, University of Warwick, Coventry, UK
| | - M Gillon
- Astrobiology Research Unit, Université de Liège, Liège, Belgium
| | - E Goffo
- Dipartimento di Fisica, Universita degli Studi di Torino, Torino, Italy
- Thüringer Landessternwarte Tautenburg, Tautenburg, Germany
| | - Y Gómez Maqueo Chew
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Ciudad de México, Mexico
| | - M Güdel
- Department of Astrophysics, University of Vienna, Vienna, Austria
| | - E W Guenther
- Thüringer Landessternwarte Tautenburg, Tautenburg, Germany
| | - M N Günther
- European Space Research and Technology Centre (ESTEC), European Space Agency (ESA), Noordwijk, The Netherlands
| | - A P Hatzes
- Thüringer Landessternwarte Tautenburg, Tautenburg, Germany
| | - Ch Helling
- Space Research Institute, Austrian Academy of Sciences, Graz, Austria
| | - K M Hesse
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA, USA
- Kavli Institute for Astrophysics and Space Research, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - S B Howell
- NASA Ames Research Center, Moffett Field, CA, USA
| | - S Hoyer
- Aix Marseille Univ., CNRS, CNES, LAM, Marseille, France
| | - K Ikuta
- Department of Multi-Disciplinary Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan
| | - K G Isaak
- European Space Research and Technology Centre (ESTEC), European Space Agency (ESA), Noordwijk, The Netherlands
| | - J M Jenkins
- NASA Ames Research Center, Moffett Field, CA, USA
| | - T Kagetani
- Department of Multi-Disciplinary Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan
| | - L L Kiss
- Konkoly Observatory, HUN-REN Research Centre for Astronomy and Earth Sciences, Budapest, Hungary
- Institute of Physics, ELTE Eötvös Loránd University, Budapest, Hungary
| | - T Kodama
- Komaba Institute for Science, The University of Tokyo, Tokyo, Japan
| | - J Korth
- Lund Observatory, Division of Astrophysics, Department of Physics, Lund University, Lund, Sweden
| | - K W F Lam
- Institute of Planetary Research, German Aerospace Center (DLR), Berlin, Germany
| | - J Laskar
- IMCCE, UMR8028 CNRS, Observatoire de Paris, PSL Univ., Sorbonne Univ., Paris, France
| | - D W Latham
- Center for Astrophysics | Harvard & Smithsonian, Cambridge, MA, USA
| | - A Lecavelier des Etangs
- Institut d'Astrophysique de Paris, UMR7095 CNRS, Université Pierre & Marie Curie, Paris, France
| | - J P D Leon
- Department of Multi-Disciplinary Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan
| | - J H Livingston
- Astrobiology Center, Tokyo, Japan
- National Astronomical Observatory of Japan, Tokyo, Japan
- Department of Astronomical Science, The Graduate University for Advanced Studies, SOKENDAI, Tokyo, Japan
| | - D Magrin
- INAF - Osservatorio Astronomico di Padova, Padova, Italy
| | - R A Matson
- United States Naval Observatory, Washington, DC, USA
| | - E C Matthews
- Max Planck Institute for Astronomy, Heidelberg, Germany
| | - C Mordasini
- Space Research and Planetary Sciences, Physics Institute, University of Bern, Bern, Switzerland
- Center for Space and Habitability, University of Bern, Bern, Switzerland
| | - M Mori
- Department of Multi-Disciplinary Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan
| | - M Moyano
- Instituto de Astronomía, Universidad Católica del Norte, Antofagasta, Chile
| | - M Munari
- INAF - Osservatorio Astrofisico di Catania, Catania, Italy
| | - F Murgas
- Instituto de Astrofisica de Canarias, La Laguna, Tenerife, Spain
- Departamento de Astrofisica, Universidad de La Laguna, La Laguna, Tenerife, Spain
| | - N Narita
- Instituto de Astrofisica de Canarias, La Laguna, Tenerife, Spain
- Komaba Institute for Science, The University of Tokyo, Tokyo, Japan
- Astrobiology Center, Tokyo, Japan
| | - V Nascimbeni
- INAF - Osservatorio Astronomico di Padova, Padova, Italy
| | - G Olofsson
- Department of Astronomy, Stockholm University, AlbaNova University Center, Stockholm, Sweden
| | - H L M Osborne
- Mullard Space Science Laboratory, University College London, Dorking, UK
| | - R Ottensamer
- Department of Astrophysics, University of Vienna, Vienna, Austria
| | - I Pagano
- INAF - Osservatorio Astrofisico di Catania, Catania, Italy
| | - H Parviainen
- Instituto de Astrofisica de Canarias, La Laguna, Tenerife, Spain
- Departamento de Astrofisica, Universidad de La Laguna, La Laguna, Tenerife, Spain
| | - G Peter
- Institute of Optical Sensor Systems, German Aerospace Center (DLR), Berlin, Germany
| | - G Piotto
- INAF - Osservatorio Astronomico di Padova, Padova, Italy
- Dipartimento di Fisica e Astronomia "Galileo Galilei", Universita degli Studi di Padova, Padova, Italy
| | - D Pollacco
- Department of Physics, University of Warwick, Coventry, UK
| | - D Queloz
- Cavendish Laboratory, University of Cambridge, Cambridge, UK
- Department of Physics, ETH Zurich, Zurich, Switzerland
| | - S N Quinn
- Center for Astrophysics | Harvard & Smithsonian, Cambridge, MA, USA
| | - A Quirrenbach
- Landessternwarte, Zentrum für Astronomie der Universität Heidelberg, Heidelberg, Germany
| | - R Ragazzoni
- INAF - Osservatorio Astronomico di Padova, Padova, Italy
- Dipartimento di Fisica e Astronomia "Galileo Galilei", Universita degli Studi di Padova, Padova, Italy
| | - N Rando
- European Space Research and Technology Centre (ESTEC), European Space Agency (ESA), Noordwijk, The Netherlands
| | - F Ratti
- European Space Research and Technology Centre (ESTEC), European Space Agency (ESA), Noordwijk, The Netherlands
| | - H Rauer
- Institute of Planetary Research, German Aerospace Center (DLR), Berlin, Germany
- Zentrum für Astronomie und Astrophysik, Technische Universität Berlin, Berlin, Germany
- Institut für Geologische Wissenschaften, Freie Universität Berlin, Berlin, Germany
| | - S Redfield
- Astronomy Department, Wesleyan University, Middletown, CT, USA
- Van Vleck Observatory, Wesleyan University, Middletown, CT, USA
| | - I Ribas
- Institut de Ciencies de l'Espai (ICE-CSIC), Bellaterra, Spain
- Institut d'Estudis Espacials de Catalunya (IEEC), Barcelona, Spain
| | - G R Ricker
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA, USA
- Kavli Institute for Astrophysics and Space Research, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - A Rudat
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA, USA
- Kavli Institute for Astrophysics and Space Research, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - L Sabin
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Ensenada, Mexico
| | - S Salmon
- Observatoire Astronomique de l'Université de Genève, Versoix, Switzerland
| | - N C Santos
- Instituto de Astrofisica e Ciencias do Espaco, Universidade do Porto, Porto, Portugal
- Departamento de Fisica e Astronomia, Faculdade de Ciencias, Universidade do Porto, Porto, Portugal
| | - G Scandariato
- INAF - Osservatorio Astrofisico di Catania, Catania, Italy
| | - N Schanche
- Center for Space and Habitability, University of Bern, Bern, Switzerland
- Department of Astronomy, University of Maryland, College Park, MD, USA
| | - J E Schlieder
- NASA Goddard Space Flight Center, Greenbelt, MD, USA
| | - S Seager
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA, USA
- Kavli Institute for Astrophysics and Space Research, Massachusetts Institute of Technology, Cambridge, MA, USA
- Department of Earth, Atmospheric and Planetary Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA
- Department of Aeronautics and Astronautics, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - D Ségransan
- Observatoire Astronomique de l'Université de Genève, Versoix, Switzerland
| | - A Shporer
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA, USA
- Kavli Institute for Astrophysics and Space Research, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - A E Simon
- Space Research and Planetary Sciences, Physics Institute, University of Bern, Bern, Switzerland
| | - A M S Smith
- Institute of Planetary Research, German Aerospace Center (DLR), Berlin, Germany
| | - S G Sousa
- Instituto de Astrofisica e Ciencias do Espaco, Universidade do Porto, Porto, Portugal
| | - M Stalport
- Space sciences, Technologies and Astrophysics Research (STAR) Institute, Université de Liège, Liège, Belgium
| | - Gy M Szabó
- Gothard Astrophysical Observatory, ELTE Eötvös Loránd University, Szombathely, Hungary
- HUN-REN-ELTE Exoplanet Research Group, Szombathely, Hungary
| | - N Thomas
- Space Research and Planetary Sciences, Physics Institute, University of Bern, Bern, Switzerland
| | - A Tuson
- Cavendish Laboratory, University of Cambridge, Cambridge, UK
| | - S Udry
- Observatoire Astronomique de l'Université de Genève, Versoix, Switzerland
| | - A M Vanderburg
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA, USA
- Kavli Institute for Astrophysics and Space Research, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - V Van Eylen
- Mullard Space Science Laboratory, University College London, Dorking, UK
| | - V Van Grootel
- Space sciences, Technologies and Astrophysics Research (STAR) Institute, Université de Liège, Liège, Belgium
| | - J Venturini
- Observatoire Astronomique de l'Université de Genève, Versoix, Switzerland
| | - I Walter
- Institute of Optical Sensor Systems, German Aerospace Center (DLR), Berlin, Germany
| | - N A Walton
- Institute of Astronomy, University of Cambridge, Cambridge, UK
| | - N Watanabe
- Department of Multi-Disciplinary Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan
| | - J N Winn
- Department of Astrophysical Sciences, Princeton University, Princeton, NJ, USA
| | - T Zingales
- Dipartimento di Fisica e Astronomia "Galileo Galilei", Universita degli Studi di Padova, Padova, Italy
| |
Collapse
|
4
|
Wilson TG, Baghel M, Kaur N, Moutzouros V, Davis J, Ali SA. Characterization of miR-335-5p and miR-335-3p in human osteoarthritic tissues. Arthritis Res Ther 2023; 25:105. [PMID: 37328905 PMCID: PMC10273720 DOI: 10.1186/s13075-023-03088-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2023] [Accepted: 06/06/2023] [Indexed: 06/18/2023] Open
Abstract
OBJECTIVE We aimed to characterize the expression patterns, gene targets, and functional effects of miR-335-5p and miR-335-3p among seven primary human knee and hip osteoarthritic tissue types. METHODS We collected synovial fluid, subchondral bone, articular cartilage, synovium, meniscus/labrum, infrapatellar/acetabular fat, anterior cruciate ligament/ligamentum teres, and vastus medialis oblique/quadratus femoris muscle (n = 7-20) from surgical patients with early- or late-stage osteoarthritis (OA) and quantified miR-335-5p and miR-335-3p expression by real-time PCR. Predicted gene targets were measured in knee OA infrapatellar fat following miRNA inhibitor transfection (n = 3), and prioritized gene targets were validated following miRNA inhibitor and mimic transfection (n = 6). Following pathway analyses, we performed Oil-Red-O staining to assess changes in total lipid content in infrapatellar fat. RESULTS Showing a 227-fold increase in knee OA infrapatellar fat (the highest expressing tissue) versus meniscus (the lowest expressing tissue), miR-335-5p was more abundant than miR-335-3p (92-fold increase). MiR-335-5p showed higher expression across knee tissues versus hip tissues, and in late-stage versus early-stage knee OA fat. Exploring candidate genes, VCAM1 and MMP13 were identified as putative direct targets of miR-335-5p and miR-335-3p, respectively, showing downregulation with miRNA mimic transfection. Exploring candidate pathways, predicted miR-335-5p gene targets were enriched in a canonical adipogenesis network (p = 2.1e - 5). Modulation of miR-335-5p in late-stage knee OA fat showed an inverse relationship to total lipid content. CONCLUSION Our data suggest both miR-335-5p and miR-335-3p regulate gene targets in late-stage knee OA infrapatellar fat, though miR-335-5p appears to be more prominent, with tissue-, joint-, and stage-specific effects.
Collapse
Affiliation(s)
- Thomas G Wilson
- Bone and Joint Center, Henry Ford Health, 6135 Woodward Avenue, Detroit, MI, 48202, USA
- Department of Orthopedic Surgery, Henry Ford Health, Detroit, MI, USA
| | - Madhu Baghel
- Bone and Joint Center, Henry Ford Health, 6135 Woodward Avenue, Detroit, MI, 48202, USA
- Department of Orthopedic Surgery, Henry Ford Health, Detroit, MI, USA
| | - Navdeep Kaur
- Bone and Joint Center, Henry Ford Health, 6135 Woodward Avenue, Detroit, MI, 48202, USA
- Department of Orthopedic Surgery, Henry Ford Health, Detroit, MI, USA
| | | | - Jason Davis
- Department of Orthopedic Surgery, Henry Ford Health, Detroit, MI, USA
| | - Shabana Amanda Ali
- Bone and Joint Center, Henry Ford Health, 6135 Woodward Avenue, Detroit, MI, 48202, USA.
- Department of Orthopedic Surgery, Henry Ford Health, Detroit, MI, USA.
- Department of Physiology, Michigan State University, East Lansing, MI, USA.
- Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA.
| |
Collapse
|
5
|
Wilson TG, Iyengar AJ, Zentner D, Zannino D, d'Udekem Y, Konstantinov IE. Liver Cirrhosis After the Fontan Procedure: Impact of Atrioventricular Valve Failure. Ann Thorac Surg 2023; 115:664-670. [PMID: 35792167 DOI: 10.1016/j.athoracsur.2022.06.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/01/2022] [Revised: 05/25/2022] [Accepted: 06/13/2022] [Indexed: 11/28/2022]
Abstract
BACKGROUND Liver cirrhosis is now well recognized as a potential complication after the Fontan procedure, although associated risk factors and optimal timing of liver screening remain unclear. METHODS All patients who underwent an extracardiac conduit Fontan procedure at The Royal Children's Hospital, Melbourne, were identified using the Australia and New Zealand Fontan Registry. Cirrhosis was diagnosed based on liver biopsy, or a combination of imaging findings and clinical evaluation by a hepatologist. RESULTS Between 1997 and 2020, 398 patients underwent an extracardiac conduit Fontan procedure at our center, and 276 had ongoing follow-up in Victoria. Ninety-five patients (34%) underwent liver assessment at a mean age of 18.2 ± 6.7 years (11.8 ± 5.5 years post-Fontan). Fifteen patients (16%) were diagnosed with cirrhosis at a mean age of 22.7 ± 5.9 years (14.0 ± 5.2 years post-Fontan). The need for prior or concomitant atrioventricular valve repair or replacement was associated with an increased risk of cirrhosis (univariable hazard ratio [HR] 7.09, 95% confidence interval [CI] 2.13-23.61, P = .001). By multivariable analysis, factors associated with development of cirrhosis were atrioventricular valve failure prior to Fontan (HR 3.27, 95% CI 1.15-9.31, P = .026) and older age at Fontan operation (HR 1.13 per year increase, 95% CI 1.01-1.26, P = .034). The proportion of patients alive, nontransplanted, and without cirrhosis at 10, 15, and 20 years was 93.4% (95% CI 88.4%-98.7%), 79.6% (95% CI 69.7%-90.8%), and 64.6% (95% CI 51.0%-81.9%), respectively. CONCLUSIONS Early commencement of liver screening should be considered for patients with a history of atrioventricular failure during Fontan palliation.
Collapse
Affiliation(s)
- Thomas G Wilson
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Victoria, Australia; Department of Gastroenterology, The Royal Children's Hospital, Melbourne, Victoria, Australia
| | - Ajay J Iyengar
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Paediatric and Congenital Cardiac Service, Starship Children's Hospital, Auckland, New Zealand
| | - Dominica Zentner
- Department of Cardiology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia
| | - Diana Zannino
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
| | - Yves d'Udekem
- Division of Cardiac Surgery, Children's National Hospital, Washington, DC, USA
| | - Igor E Konstantinov
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Victoria, Australia; Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Victoria, Australia; Melbourne Centre for Cardiovascular Genomics and Regenerative Medicine, Melbourne, Victoria, Australia.
| |
Collapse
|
6
|
Morgado BE, Sicardy B, Braga-Ribas F, Ortiz JL, Salo H, Vachier F, Desmars J, Pereira CL, Santos-Sanz P, Sfair R, de Santana T, Assafin M, Vieira-Martins R, Gomes-Júnior AR, Margoti G, Dhillon VS, Fernández-Valenzuela E, Broughton J, Bradshaw J, Langersek R, Benedetti-Rossi G, Souami D, Holler BJ, Kretlow M, Boufleur RC, Camargo JIB, Duffard R, Beisker W, Morales N, Lecacheux J, Rommel FL, Herald D, Benz W, Jehin E, Jankowsky F, Marsh TR, Littlefair SP, Bruno G, Pagano I, Brandeker A, Collier-Cameron A, Florén HG, Hara N, Olofsson G, Wilson TG, Benkhaldoun Z, Busuttil R, Burdanov A, Ferrais M, Gault D, Gillon M, Hanna W, Kerr S, Kolb U, Nosworthy P, Sebastian D, Snodgrass C, Teng JP, de Wit J. A dense ring of the trans-Neptunian object Quaoar outside its Roche limit. Nature 2023; 614:239-243. [PMID: 36755175 DOI: 10.1038/s41586-022-05629-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2022] [Accepted: 12/06/2022] [Indexed: 02/10/2023]
Abstract
Planetary rings are observed not only around giant planets1, but also around small bodies such as the Centaur Chariklo2 and the dwarf planet Haumea3. Up to now, all known dense rings were located close enough to their parent bodies, being inside the Roche limit, where tidal forces prevent material with reasonable densities from aggregating into a satellite. Here we report observations of an inhomogeneous ring around the trans-Neptunian body (50000) Quaoar. This trans-Neptunian object has an estimated radius4 of 555 km and possesses a roughly 80-km satellite5 (Weywot) that orbits at 24 Quaoar radii6,7. The detected ring orbits at 7.4 radii from the central body, which is well outside Quaoar's classical Roche limit, thus indicating that this limit does not always determine where ring material can survive. Our local collisional simulations show that elastic collisions, based on laboratory experiments8, can maintain a ring far away from the body. Moreover, Quaoar's ring orbits close to the 1/3 spin-orbit resonance9 with Quaoar, a property shared by Chariklo's2,10,11 and Haumea's3 rings, suggesting that this resonance plays a key role in ring confinement for small bodies.
Collapse
Affiliation(s)
- B E Morgado
- Federal University of Rio de Janeiro - Observatory of Valongo, Rio de Janeiro, Brazil.
- National Observatory/MCTI, Rio de Janeiro, Brazil.
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil.
| | - B Sicardy
- LESIA, Observatory of Paris, University PSL, CNRS, UPMC, Sorbonne University, University of Paris Diderot, Sorbonne Paris City, Meudon, France
| | - F Braga-Ribas
- Federal University of Technology, Paraná (UTFPR/DAFIS), Curitiba, Brazil
| | - J L Ortiz
- Institute of Astrophysics at Andalucía, IAA-CSIC, Granada, Spain
| | - H Salo
- Space Physics and Astronomy Research unit, University of Oulu, Oulu, Finland
| | - F Vachier
- The Institute of Celestial Mechanics and Ephemeris Calculation (IMCCE), Observatory of Paris, PSL Research University, CNRS, Sorbonne University, UPMC University of Paris, University of Lille, Lille, France
| | - J Desmars
- The Institute of Celestial Mechanics and Ephemeris Calculation (IMCCE), Observatory of Paris, PSL Research University, CNRS, Sorbonne University, UPMC University of Paris, University of Lille, Lille, France
- Polytechnic Institute of Advanced Sciences (IPSA), Ivry-sur-Seine, France
| | - C L Pereira
- National Observatory/MCTI, Rio de Janeiro, Brazil
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
| | - P Santos-Sanz
- Institute of Astrophysics at Andalucía, IAA-CSIC, Granada, Spain
| | - R Sfair
- Institute for Astronomy and Astrophysics, Eberhard Karls University of Tübingen, Tübingen, Germany
- Orbital Dynamics and Planetology Group, UNESP - São Paulo State University, Guaratinguetá, Brazil
| | - T de Santana
- LESIA, Observatory of Paris, University PSL, CNRS, UPMC, Sorbonne University, University of Paris Diderot, Sorbonne Paris City, Meudon, France
- Orbital Dynamics and Planetology Group, UNESP - São Paulo State University, Guaratinguetá, Brazil
| | - M Assafin
- Federal University of Rio de Janeiro - Observatory of Valongo, Rio de Janeiro, Brazil
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
| | - R Vieira-Martins
- National Observatory/MCTI, Rio de Janeiro, Brazil
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
| | - A R Gomes-Júnior
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
- Orbital Dynamics and Planetology Group, UNESP - São Paulo State University, Guaratinguetá, Brazil
- Institute of Physics, Federal University of Uberlândia, Uberlândia, Brazil
| | - G Margoti
- Federal University of Technology, Paraná (UTFPR/DAFIS), Curitiba, Brazil
| | - V S Dhillon
- Department of Physics and Astronomy, University of Sheffield, Sheffield, UK
- Institute of Astrophysics of The Canary Islands, La Laguna, Spain
| | | | - J Broughton
- Reedy Creek Observatory, Gold Coast, Queensland, Australia
- Trans-Tasman Occultation Alliance (TTOA), Wellington, New Zealand
| | - J Bradshaw
- Samford Valley Observatory (Q79), Brisbane, Queensland, Australia
| | - R Langersek
- Algester Astronomical Observatory, Brisbane, Queensland, Australia
| | - G Benedetti-Rossi
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
- Orbital Dynamics and Planetology Group, UNESP - São Paulo State University, Guaratinguetá, Brazil
| | - D Souami
- LESIA, Observatory of Paris, University PSL, CNRS, UPMC, Sorbonne University, University of Paris Diderot, Sorbonne Paris City, Meudon, France
- Observatory of the Côte d'Azur, Lagrange Laboratory UMR7293 CNRS, Nice, France
- naXys, University of Namur, Namur, Belgium
| | - B J Holler
- Space Telescope Science Institute, Baltimore, MD, USA
| | - M Kretlow
- Institute of Astrophysics at Andalucía, IAA-CSIC, Granada, Spain
- International Occultation Timing Association / European Section, Hannover, Germany
- International Amateur Observatory e.V. (IAS), Mittenwalde, Germany
| | - R C Boufleur
- National Observatory/MCTI, Rio de Janeiro, Brazil
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
| | - J I B Camargo
- National Observatory/MCTI, Rio de Janeiro, Brazil
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
| | - R Duffard
- Institute of Astrophysics at Andalucía, IAA-CSIC, Granada, Spain
| | - W Beisker
- International Occultation Timing Association / European Section, Hannover, Germany
- International Amateur Observatory e.V. (IAS), Mittenwalde, Germany
| | - N Morales
- Institute of Astrophysics at Andalucía, IAA-CSIC, Granada, Spain
| | - J Lecacheux
- LESIA, Observatory of Paris, University PSL, CNRS, UPMC, Sorbonne University, University of Paris Diderot, Sorbonne Paris City, Meudon, France
| | - F L Rommel
- National Observatory/MCTI, Rio de Janeiro, Brazil
- Interinstitutional e-Astronomy Laboratory (LIneA), Rio de Janeiro, Brazil
| | - D Herald
- Trans-Tasman Occultation Alliance (TTOA), Wellington, New Zealand
| | - W Benz
- Institute of Physics, University of Bern, Bern, Switzerland
- Center for Space and Habitability, University of Bern, Bern, Switzerland
| | - E Jehin
- STAR Institute, University of Liège, Liège, Belgium
| | - F Jankowsky
- Heidelberg-Königstuhl State Observatory, Heidelberg, Germany
| | - T R Marsh
- Department of Physics, University of Warwick, Coventry, UK
| | - S P Littlefair
- Department of Physics and Astronomy, University of Sheffield, Sheffield, UK
| | - G Bruno
- INAF, Catania Astrophysical Observatory, Catania, Italy
| | - I Pagano
- INAF, Catania Astrophysical Observatory, Catania, Italy
| | - A Brandeker
- Department of Astronomy, Stockholm University, AlbaNova University Center, Stockholm, Sweden
| | - A Collier-Cameron
- Centre for Exoplanet Science, SUPA School of Physics and Astronomy, University of St Andrews, North Haugh, St Andrews, UK
| | - H G Florén
- Department of Astronomy, Stockholm University, AlbaNova University Center, Stockholm, Sweden
| | - N Hara
- Astronomical Observatory at the University of Geneva, Versoix, Switzerland
| | - G Olofsson
- Department of Astronomy, Stockholm University, AlbaNova University Center, Stockholm, Sweden
| | - T G Wilson
- Centre for Exoplanet Science, SUPA School of Physics and Astronomy, University of St Andrews, North Haugh, St Andrews, UK
| | - Z Benkhaldoun
- Oukaimeden Observatory, High Energy Physics and Astrophysics Laboratory, FSSM, Cadi Ayyad University, Marrakech, Morocco
| | - R Busuttil
- School of Physical Sciences, The Open University, Walton Hall, Milton Keynes, UK
| | - A Burdanov
- Department of Earth, Atmospheric and Planetary Sciences, MIT, Cambridge, MA, USA
| | - M Ferrais
- Laboratory of Astrophysics of Marseille, University of Aix Marseille, CNRS, CNES, Marseille, France
| | - D Gault
- Trans-Tasman Occultation Alliance (TTOA), Wellington, New Zealand
| | - M Gillon
- Astrobiology Research Unit, University of Liège, Liège, Belgium
| | - W Hanna
- Trans-Tasman Occultation Alliance (TTOA), Wellington, New Zealand
| | - S Kerr
- Trans-Tasman Occultation Alliance (TTOA), Wellington, New Zealand
- Astronomical Association of Queensland, Pimpama, Queensland, Australia
| | - U Kolb
- School of Physical Sciences, The Open University, Walton Hall, Milton Keynes, UK
| | - P Nosworthy
- Trans-Tasman Occultation Alliance (TTOA), Wellington, New Zealand
| | - D Sebastian
- School of Physics and Astronomy, University of Birmingham, Birmingham, UK
| | - C Snodgrass
- Institute for Astronomy, University of Edinburgh, Royal Observatory, Edinburgh, UK
| | - J P Teng
- AGORA Observatory of Makes, AGORA, La Rivière, France
| | - J de Wit
- Department of Earth, Atmospheric and Planetary Sciences, MIT, Cambridge, MA, USA
| |
Collapse
|
7
|
Payne E, Garden F, d'Udekem Y, Weintraub R, McCallum Z, Wightman H, Zentner D, Cordina R, Wilson TG, Ayer J. Prolonged Enteral Tube Feeding in Infants With a Functional Single Ventricle Is Associated With Adverse Outcomes After Fontan Completion. J Pediatr 2023:S0022-3476(23)00042-2. [PMID: 36708874 DOI: 10.1016/j.jpeds.2023.01.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/14/2022] [Revised: 01/13/2023] [Accepted: 01/22/2023] [Indexed: 01/26/2023]
Abstract
OBJECTIVES To define the baseline characteristics of long-term tube-fed single ventricle patients, investigate associations between long-term enteral tube feeding and growth, and determine associations with long-term outcomes after Fontan procedure. STUDY DESIGN We performed a retrospective cohort study of patients in the Australia and New Zealand Fontan Registry undergoing treatment at the Royal Children's Hospital, the Children's Hospital at Westmead, Royal Melbourne Hospital, and Royal Prince Alfred Hospital from 1981-2018. Patients were defined as tube-fed (TF) or non-tube-fed (NTF) based on enteral tube feeding at age 90 days. Feeding groups were compared regarding BMI trajectory, BMI at last follow-up, and long-term incidence of severe Fontan failure. RESULTS Of 390 patients (56(14%) TF, 334(86%) NTF), TF was associated with right ventricular dominance, hypoplastic left heart syndrome, Norwood procedure, increased procedures prior to Fontan, extracardiac conduit Fontan, Fontan fenestration, and atrioventricular valve repair/replacement. TF patients were less likely to be in the higher compared with lowest 0-6 month BMI trajectory (P<0.01,P=0.03), had lower 6month weight-for-age z-scores (P<0.01) and length-for-age z-scores (P=0.01). TF were less likely to be overweight/obese at pediatric follow-up (HR=0.31,95%CI:0.12-0.80;P=0.02) and more likely to be underweight at adult follow-up ((HR=16.51; 5%CI:2.70-101.10;P<0.01).TF compared with NTF was associated with increased risk of severe Fontan failure (HR=4.13;95%CI=1.65,10.31;P<0.01). CONCLUSIONS Prolonged infant enteral tube feeding is an independent marker of poor growth and adverse clinical outcomes extending long-term post-Fontan procedure.
Collapse
Affiliation(s)
- Emma Payne
- The University of Sydney, Sydney, AUSTRALIA; The University of Melbourne, Melbourne, AUSTRALIA
| | - Frances Garden
- The University of New South, Sydney, AUSTRALIA; The Ingham Institute of Applied Medical Research, Sydney, AUSTRALIA
| | | | - Robert Weintraub
- The University of Melbourne, Melbourne, AUSTRALIA; The Royal Children's Hospital, Melbourne, AUSTRALIA; The Murdoch Children's Research Institute, Melbourne, AUSTRALIA
| | - Zoe McCallum
- The Royal Children's Hospital, Melbourne, AUSTRALIA
| | | | - Dominica Zentner
- The University of Melbourne, Melbourne, AUSTRALIA; The Royal Melbourne Hospital, Melbourne, AUSTRALIA
| | - Rachael Cordina
- The University of Sydney, Sydney, AUSTRALIA; The Royal Prince Alfred Hospital, Sydney, AUSTRALIA
| | - Thomas G Wilson
- The University of Melbourne, Melbourne, AUSTRALIA; The Royal Children's Hospital, Melbourne, AUSTRALIA
| | - Julian Ayer
- The University of Sydney, Sydney, AUSTRALIA; The Heart Centre for Children, The Sydney Children's Hospital Network, Sydney, AUSTRALIA.
| |
Collapse
|
8
|
Limbri LF, Wilson TG, Oliver MR. Prevalence of irritable bowel syndrome and functional abdominal pain disorders in children with inflammatory bowel disease in remission. JGH Open 2022; 6:818-823. [PMID: 36514508 PMCID: PMC9730717 DOI: 10.1002/jgh3.12791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2021] [Accepted: 06/14/2022] [Indexed: 11/06/2022]
Abstract
Despite evidence of an increased prevalence of irritable bowel syndrome (IBS) in adults with inflammatory bowel disease (IBD) compared with the general population, the prevalence of IBS in children with IBD is unclear. In this review, we aimed to identify the reported prevalence of IBS or functional abdominal pain disorders (FAPDs) in children with IBD in remission. A search of three databases (MEDLINE, Embase, and PubMed) was performed to identify studies reporting the prevalence of IBS or FAPDs in pediatric patients with IBD in remission. A total of 60 studies were identified, with four eligible studies remaining following abstract screening. In children with IBD in remission, the overall prevalence of IBS ranged between 3.9 and 16.1%, and the overall prevalence of FAPDs ranged between 9.6 and 29.5%. The prevalence of FAPDs in patients in biomarker-based remission was generally higher than those in clinical remission (range 16-22.5% vs 9.6-16.7%, respectively). There is a paucity of literature reporting on the prevalence of IBS or FAPDs in children with IBD in remission. Despite the differences in criteria used to define IBD remission in the included articles, there seems to be an increased overall prevalence of IBS or FAPDs in children with IBD.
Collapse
Affiliation(s)
- Lydia F Limbri
- Melbourne Medical SchoolThe University of MelbourneMelbourneVictoriaAustralia
| | - Thomas G Wilson
- Department of Gastroenterology and Clinical NutritionThe Royal Children's HospitalMelbourneVictoriaAustralia,Department of Paediatrics, Faculty of MedicineThe University of MelbourneMelbourneVictoriaAustralia
| | - Mark R Oliver
- Department of Gastroenterology and Clinical NutritionThe Royal Children's HospitalMelbourneVictoriaAustralia,Department of Paediatrics, Faculty of MedicineThe University of MelbourneMelbourneVictoriaAustralia
| |
Collapse
|
9
|
Payne E, Garden F, d'Udekem Y, McCallum Z, Wightman H, Zannino D, Zentner D, Cordina R, Weintraub R, Wilson TG, Ayer J. Body Mass Index Trajectory and Outcome Post Fontan Procedure. J Am Heart Assoc 2022; 11:e025931. [PMID: 36073652 DOI: 10.1161/jaha.122.025931] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background Patients with a single ventricle who experience early life growth failure suffer high morbidity and mortality in the perisurgical period. However, long-term implications of poor infant growth, as well as associations between body mass index (BMI) and outcome in adulthood, remain unclear. We aimed to model BMI trajectories of patients with a single ventricle undergoing a Fontan procedure to determine trajectory-based differences in baseline characteristics and long-term clinical outcomes. Methods and Results We performed a retrospective analysis of medical records from patients in the Australia and New Zealand Fontan Registry receiving treatment at the Royal Children's Hospital, The Children's Hospital at Westmead, Royal Melbourne Hospital, and Royal Prince Alfred Hospital from 1981 to 2018. BMI trajectories were modeled in 496 patients using latent class growth analysis from 0 to 6 months, 6 to 60 months, and 5 to 16 years. Trajectories were compared regarding long-term incidence of severe Fontan failure (defined as mortality, heart transplantation, Fontan takedown, or New York Heart Association class III/IV heart failure). Three trajectories were found for male and female subjects at each age group-lower, middle, higher. Subjects in the lower trajectory at 0 to 6 months were more likely to have an atriopulmonary Fontan and experienced increased mortality long term. No association was found between higher BMI trajectory, current BMI, and long-term outcome. Conclusions Poor growth in early life correlates with increased long-term severe Fontan failure. Delineation of distinct BMI trajectories can be used in larger and older cohorts to find optimal BMI targets for patient outcome.
Collapse
Affiliation(s)
- Emma Payne
- The University of Sydney Sydney Australia.,The University of Melbourne Melbourne Australia
| | - Frances Garden
- The University of New South Wales Sydney Australia.,The Ingham Institute of Applied Medical Research Sydney Australia
| | | | - Zoe McCallum
- The University of Melbourne Melbourne Australia.,The Royal Children's Hospital Melbourne Australia
| | | | - Diana Zannino
- Murdoch Children's Research Institute Melbourne Australia
| | - Dominica Zentner
- The University of Melbourne Melbourne Australia.,Royal Melbourne Hospital Melbourne Australia
| | - Rachael Cordina
- The University of Sydney Sydney Australia.,The Royal Prince Alfred Hospital Sydney Australia
| | - Robert Weintraub
- The University of Melbourne Melbourne Australia.,The Royal Children's Hospital Melbourne Australia.,Murdoch Children's Research Institute Melbourne Australia
| | - Thomas G Wilson
- The University of Melbourne Melbourne Australia.,The Royal Children's Hospital Melbourne Australia
| | - Julian Ayer
- The University of Sydney Sydney Australia.,The Heart Centre for Children The Sydney Children's Hospital Network Sydney Australia
| |
Collapse
|
10
|
Wilson TG, Iyengar AJ, Zentner D, d'Udekem Y. Surveillance of End-Organ Damage in Fontan Patients Prior to Transition to Adult Care: Are We There Yet? Heart Lung Circ 2021; 31:544-548. [PMID: 34756660 DOI: 10.1016/j.hlc.2021.10.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2020] [Revised: 07/26/2021] [Accepted: 10/07/2021] [Indexed: 11/17/2022]
Abstract
BACKGROUND Recently published guidelines and consensus statements have outlined recommended screening practices for monitoring of end-organ dysfunction in Fontan patients. We reviewed the current approach to end-organ screening in a local population of Fontan patients at the time of transition to adult care. METHODS Patient data from the Australia and New Zealand Fontan Registry and patient medical records were used to review investigations performed in Fontan patients transitioned from The Royal Children's Hospital Melbourne to an adult centre between 1 July 2015 and 30 June 2020. RESULTS A total of 32 patients were referred for transition to an adult centre between 1 July 2015 and 30 June 2020 at a mean age of 18.5±0.7 years (12.7±2.5 years post-Fontan). Liver function tests were performed in 22 patients (69%) within 5 years prior to transition and were abnormal in 15 patients (68%). Liver ultrasound was performed in 13 patients (41%) within 5 years prior to the date of transition, of whom 10 (77%) had abnormal findings (features suggestive of hepatic fibrosis in seven [54%], cirrhosis in two [15%], and portal hypertension in three [23%]). Fourteen (14) patients (44%) had no record of a liver ultrasound being performed between the date of the Fontan procedure and the time of transition to adult care. Hepatocellular carcinoma was diagnosed in one patient at 18 months following transition. A total of 24 patients (75%) had a serum creatinine measured within the 5 years prior to transition, and two (8%) had an estimated glomerular filtration rate (eGFR) less than 90 ml/min/1.73 m2. No patient had a urine protein-creatinine ratio measured between the date of the Fontan procedure and the time of transition to adult care. CONCLUSIONS In this study we have identified that the majority of patients transitioned from a tertiary paediatric centre to an adult centre within the last 5 years did not undergo routine surveillance for end-organ dysfunction. Routine screening for end-organ complications of the Fontan circulation should be incorporated into clinical practice and is an important part of Fontan patient care both pre- and post-transition to adult services.
Collapse
Affiliation(s)
- Thomas G Wilson
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Vic, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Vic, Australia; Department of Gastroenterology, The Royal Children's Hospital, Melbourne, Vic, Australia.
| | - Ajay J Iyengar
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Vic, Australia; Paediatric and Congenital Cardiac Service, Starship Children's Hospital, Auckland, New Zealand
| | - Dominica Zentner
- Department of Cardiology, The Royal Melbourne Hospital, Vic, Australia; Department of Medicine, The University of Melbourne, Vic, Australia
| | - Yves d'Udekem
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Vic, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Vic, Australia; Division of Cardiac Surgery, Children's National Hospital, Washington, DC, USA
| |
Collapse
|
11
|
Yan A, Hanna A, Wilson TG, Deraniyagala R, Krauss DJ, Grzywacz VP, Yan D, Wilson GD. Correlation between tumor voxel dose response matrix and tumor biomarker profile in patients with head and neck squamous cell carcinoma. Radiother Oncol 2021; 164:196-201. [PMID: 34619238 DOI: 10.1016/j.radonc.2021.09.027] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2021] [Revised: 09/13/2021] [Accepted: 09/24/2021] [Indexed: 12/20/2022]
Abstract
BACKGROUND We have developed a novel imaging analysis procedure that is highly predictive of local failure after chemoradiation in head and neck cancer. In this study we investigated whether any pretreatment biomarkers correlated with key imaging parameters. METHODS Pretreatment biopsy material was available for 28 patients entered into an institutional trial of adaptive radiotherapy in which FDG-PET images were collected weekly during treatment. The biopsies were immunohistochemically stained for CD44, EGFR, GLUT1, ALDH1, Ki-67 and p53 and quantified using image analysis. Expression levels were correlated with previously derived imaging parameters, the pretreatment SUVmax and the dose response matrix (DRM). RESULTS The different parameters of the SUVmax and DRM did not correlate with each other. We observed a positive and highly significant (p = 0.0088) correlation between CD44 expression and volume of tumor with a DRM greater than 0.8. We found no correlation between any DRM parameter and GLUT1, p53, Ki-67 and EGFR or ALDH1. GLUT1 expression did correlate with the maximum SUV0 and the volume of tumor with an SUV0 greater than 20. CONCLUSIONS The pretreatment SUVmax and DRM are independent imaging parameters that combine to predict local recurrence. The significant correlation between CD44 expression, a known cancer stem cell (CSC) marker, and volume of tumor with a DRM greater than 0.8 is consistent with concept that specific foci of cells are responsible for tumor recurrence and that CSCs may be randomly distributed in tumors in specific niches. Dose painting these small areas may lead to improved tumor control.
Collapse
Affiliation(s)
- Arthur Yan
- Department of Radiation Oncology, Beaumont Health, USA
| | - Alaa Hanna
- Department of Radiation Oncology, Beaumont Health, USA
| | | | | | | | | | - Di Yan
- Department of Radiation Oncology, Beaumont Health, USA
| | | |
Collapse
|
12
|
Wilson GD, Wilson TG, Hanna A, Fontanesi G, Kulchycki J, Buelow K, Pruetz BL, Michael DB, Chinnaiyan P, Maddens ME, Martinez AA, Fontanesi J. Low Dose Brain Irradiation Reduces Amyloid-β and Tau in 3xTg-AD Mice. J Alzheimers Dis 2021; 75:15-21. [PMID: 32280098 DOI: 10.3233/jad-200030] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
We have previously reported that low doses of external beam ionizing irradiation reduced amyloid-β (Aβ) plaques and improved cognition in APP/PS1 mice. In this study we investigated the effects of radiation in an age-matched series of 3xTg-AD mice. Mice were hemibrain-irradiated with 5 fractions of 2 Gy and sacrificed 8 weeks after the end of treatment. Aβ and tau were assessed using immunohistochemistry and quantified using image analysis with Definiens Tissue Studio. We observed a significant reduction in Aβ plaque burden and tau staining; these two parameters were significantly correlated. This preliminary data is further support that low doses of radiation may be beneficial in Alzheimer's disease.
Collapse
Affiliation(s)
- George D Wilson
- Radiation Oncology Department, Beaumont Health, Royal Oak, MI, USA
| | - Thomas G Wilson
- Radiation Oncology Department, Beaumont Health, Royal Oak, MI, USA
| | - Alaa Hanna
- Radiation Oncology Department, Beaumont Health, Royal Oak, MI, USA
| | | | - Justin Kulchycki
- Radiation Oncology Department, Beaumont Health, Royal Oak, MI, USA
| | - Katie Buelow
- Radiation Oncology Department, Beaumont Health, Royal Oak, MI, USA
| | | | - Daniel B Michael
- Michigan Head and Spine Institute, Southfield, MI, USA.,Department of Neurosurgery, Oakland University William Beaumont School of Medicine, Royal Oak, MI, USA
| | | | - Michael E Maddens
- Department of Internal Medicine, Oakland University William Beaumont School of Medicine, Royal Oak, MI, USA
| | - Alvaro A Martinez
- Radiation Oncology Institute, Division of Michigan Healthcare Professionals, Farmington Hills, MI, USA
| | - James Fontanesi
- Radiation Oncology Department, Beaumont Health, Royal Oak, MI, USA.,Department of Neurosurgery, Oakland University William Beaumont School of Medicine, Royal Oak, MI, USA
| |
Collapse
|
13
|
Daems JJN, Attard C, Van Den Helm S, Breur J, D'Udekem Y, du Plessis K, Wilson TG, Winlaw D, Gentles TL, Monagle P, Ignjatovic V. Cross-sectional assessment of haemostatic profile and hepatic dysfunction in Fontan patients. Open Heart 2021; 8:openhrt-2020-001460. [PMID: 33972403 PMCID: PMC8112412 DOI: 10.1136/openhrt-2020-001460] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/23/2020] [Revised: 12/24/2020] [Accepted: 02/22/2021] [Indexed: 12/20/2022] Open
Abstract
Background Fontan-associated liver disease is accompanied by a hypercoagulable state. While hepatic dysfunction in Fontan patients is common, its relationship with haemostatic changes and clinical outcomes in this patient population remains unclear. Objective To correlate liver dysfunction and haemostatic profiles with clinical outcomes in the Fontan population. Patients/methods Patients were enrolled in a multicentre, cross-sectional study in Australia and New Zealand. Hepatic structure and function were assessed using serum-based calculations (Fibrotest and model for end-stage liver disease excluding international normalised ratio scores). Haemostatic profiles were assessed by Thrombin Generation. Platelet function was assessed via Platelet Factor 4 (PF4) and P-selectin (P-SEL). Clinical outcomes were obtained from the Australian and New Zealand Fontan Registry. Results Seventy-three patients participated in the study (mean age 18.9±8.5 years with a mean of 13.5±6.9 years post-Fontan). The Endogenous Thrombin Potential (ETP) for patients who suffered thrombotic events (TE) (1366.4±66.2 nM/min) was higher compared with patients with major bleeding events (1011.1±138.4 nM/min) (p=0.03). Except for a negative correlation between Fibrotest-score and PF4 (p=0.045), PF4 and P-SEL concentrations did not correlate with markers of hepatic dysfunction or structural abnormality. Conclusions Increased ETP is associated with TE during clinical follow-up after Fontan. This study reinforces that hepatic dysfunction may contribute to the derangement of coagulation factors, impacting the individual risk of haemostatic complications for the Fontan population.
Collapse
Affiliation(s)
| | - Chantal Attard
- Heamatology Research, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
| | - Suelyn Van Den Helm
- Heamatology Research, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
| | - Johannes Breur
- Paediatric Cardiology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands
| | - Yves D'Udekem
- Heart Research, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
| | - Karin du Plessis
- Paediatrics, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
| | - Thomas G Wilson
- Heart Research, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia.,Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia
| | - David Winlaw
- Heart Centre for Children, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.,Cardiothoracic Surgery, St Vincent's Hospital, Sydney, New South Wales, Australia
| | - Thomas L Gentles
- Paediatric and Congenital Cardiology, Starship Childrens Hospital, Auckland, New Zealand
| | - Paul Monagle
- Heamatology Research, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia.,Paediatrics and Clinical Hematology, The Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia
| | - Vera Ignjatovic
- Heamatology Research, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
| |
Collapse
|
14
|
Wilson TG, Winter H, Taylor H, Herbert C. Treating brain metastases in melanoma: What is the optimal CNS-directed and systemic management? J Radiosurg SBRT 2021; 7:279-285. [PMID: 34631229 PMCID: PMC8492052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 04/16/2021] [Accepted: 07/09/2021] [Indexed: 06/13/2023]
Abstract
Treatments for melanoma have significantly advanced with the approval of targeted treatments against the BRAF/MEK pathway and immunotherapy in the form of checkpoint inhibitors. Studies have shown the effectiveness of these treatments against brain metastases. However, the optimum treatment strategy utilising CNS-directed treatments such as stereotactic radiosurgery (SRS) and neurosurgical resection is less clear. Over six years, 70 patients with metastatic melanoma were treated for brain metastases at a tertiary treatment centre. The median overall survival (OS) for all patients was 10.2 months. 51 patients received localised treatment; 7 resection (median OS 10 months), 11 resection and SRS (median OS 17.3 months) and 33 SRS alone (median OS 17.4 months). For patients treated with SRS those who had <2 cm3 treated had a better median OS (20.5 months) compared to those who had >2 cm3 treated (12 months). 69 Patients received systemic treatment. The median OS of patients who did not have CNS-directed treatment was poor (median OS 1.2 months). Patients treated with first line dual immunotherapy had the best median OS (26.7 months), compared to anti-PD-1 (14.1 months), ipilimumab (14.3 months) and kinase inhibitors (10.9 months). Despite advancements in treatment, the development of brain metastases in melanoma is associated with worse outcomes. A combination of CNS-directed and systemic treatment is important to improve survival. Dual immunotherapy appears to be the most effective systemic treatment and the use of SRS improved outcomes. As metastatic melanoma treatments evolve there need to be an ongoing focus to ensure these strategies adequately treat intracranial disease.
Collapse
Affiliation(s)
| | - Helen Winter
- Bristol Haematology and Oncology Centre, Bristol, UK
| | - Hannah Taylor
- Bristol Haematology and Oncology Centre, Bristol, UK
| | | |
Collapse
|
15
|
Khuong JN, Wilson TG, Iyengar AJ, d'Udekem Y. Acute and Chronic Kidney Disease Following Congenital Heart Surgery: A Review. Ann Thorac Surg 2020; 112:1698-1706. [PMID: 33310148 DOI: 10.1016/j.athoracsur.2020.10.054] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/14/2020] [Revised: 09/13/2020] [Accepted: 10/05/2020] [Indexed: 01/14/2023]
Abstract
BACKGROUND There is an increasing prevalence of chronic kidney disease in the population of adults currently living with congenital heart disease. A considerable proportion of children who undergo congenital heart surgery experience postoperative acute kidney injury. Whether there is an association between acute kidney injury after cardiac surgery in childhood and development of chronic kidney disease is unclear. METHODS Three electronic databases were searched to capture relevant studies exploring the relationship between acute kidney injury after congenital heart surgery in children and progression to chronic kidney disease. RESULTS A literature search identified a total of 212 research articles, 7 of which were selected for in-depth review. CONCLUSIONS There is a likely association between acute kidney injury in children undergoing congenital heart surgery and progression to chronic kidney disease. Research should be developed to mitigate factors contributing to postoperative acute kidney injury in neonates, infants, and children undergoing cardiac surgery. Better targeted follow-up protocols to monitor renal function in children undergoing cardiac surgery should be implemented. A universal definition for acute kidney injury and chronic kidney disease is needed to improve detection and research in this field.
Collapse
Affiliation(s)
- Jacqueline N Khuong
- Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, University of Melbourne, Melbourne, Australia
| | - Thomas G Wilson
- Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, University of Melbourne, Melbourne, Australia
| | - Ajay J Iyengar
- Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, University of Melbourne, Melbourne, Australia
| | - Yves d'Udekem
- Division of Cardiac Surgery, Children's National Hospital, Washington, DC.
| |
Collapse
|
16
|
Wilson GD, Wilson TG, Hanna A, Dabjan M, Buelow K, Torma J, Marples B, Galoforo S. Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer. Clin Transl Radiat Oncol 2020; 26:15-23. [PMID: 33251343 PMCID: PMC7677653 DOI: 10.1016/j.ctro.2020.11.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 11/02/2020] [Accepted: 11/03/2020] [Indexed: 01/05/2023] Open
Abstract
We evaluated radiation with dual EGFR and PI3K targeting in head and neck cancer. Dacomitinib, showed an inverse correlation between growth inhibition and EGFR expression. Gedatolisib was effective in each cell line. Neither drug caused radiosensitization in vitro. Gedatolisib was relatively ineffective in vivo in combination with dacomitinib and/or radiation. Dacomitinib was highly effective alone and in combination with radiation and/or gedatolisib. Immunoblotting studies in vivo mirrored the effects seen with growth delay.
Background and purpose There has been little success targeting individual genes in combination with radiation in head and neck cancer. In this study we investigated whether targeting two key pathways simultaneously might be more effective. Materials and methods We studied the effect of combining dacomitinib (pan-HER, irreversible inhibitor) and gedatolisib (dual PI3K/MTOR inhibitor) with radiation in well characterized, low passage xenograft models of HNSCC in vitro and in vivo. Results Dacomitinib showed differential growth inhibition in vitro that correlated to EGFR expression whilst gedatolisib was effective in both cell lines. Neither agent radiosensitized the cell lines in vitro. In vivo studies demonstrated that dacomitinib was an effective agent alone and in combination with radiation whilst the addition of gedatolisib did not enhance the effect of these two modalities despite inhibiting phosphorylation of key genes in the PI3K/MTOR pathway. Conclusions Our results showed that combining two drugs with radiation provided no added benefit compared to the single most active drug. Dacomitinib deserves more investigation as a radiation sensitizing agent in HNSCC.
Collapse
Affiliation(s)
- George D Wilson
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States
| | - Thomas G Wilson
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States
| | - Alaa Hanna
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States
| | - Mohamad Dabjan
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States
| | - Katie Buelow
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States
| | - John Torma
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States
| | - Brian Marples
- Department of Radiation Oncology, University of Rochester, Rochester, NY, United States
| | - Sandra Galoforo
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States
| |
Collapse
|
17
|
Jain SS, Schramm STJ, Siddiqui DA, Huo W, Palmer KL, Wilson TG, Rodrigues DC. Effects of multiple implantations of titanium healing abutments: Surface characteristics and microbial colonization. Dent Mater 2020; 36:e279-e291. [PMID: 32591158 PMCID: PMC7429256 DOI: 10.1016/j.dental.2020.05.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2019] [Revised: 04/06/2020] [Accepted: 05/24/2020] [Indexed: 11/28/2022]
Abstract
OBJECTIVE Very few studies have investigated dental implant components involved in the early stage of healing, especially the implant healing abutment (IHA), despite its vital role in soft tissue contouring and shaping after implant placement. Although these components are labelled by the manufacturer for "single-use only," it is a common clinical practice to clean, sterilize, and reuse them. METHODS In the present study, IHAs after single and multiple implantations were retrieved as per standard procedures, and biological material isolated from the surface was subjected to 16S rRNA sequence analysis. The microbiome analysis was followed by cleaning and sterilization in order to replicate clinical sterilization techniques. Following sterilization, retrievals were subjected to surface characterization with optical and scanning electron microscopy to investigate surface features, and electrochemical testing was performed to evaluate corrosion behavior. RESULTS The microbiota was comprised of early colonizers including Streptococcus species and secondary anaerobic colonizers such as Fusobacterium, Capnocytophaga, and Prevotella species. The surface analysis revealed that irrespective of the cleaning and sterilization techniques, the pristine, homogeneous surface of the new, unused IHAs could not be restored. Both single and multiple-use IHAs had severe surface changes including discoloration, major abrasions, biological contamination, and the IHA retrievals exhibited higher corrosion rate as compared to control specimens. SIGNIFICANCE Reusing IHAs multiple times may not be a prudent practice as the microbial colonization and surface changes caused by using this component multiple times may affect the performance of IHAs in soft tissue healing.
Collapse
Affiliation(s)
- Sanjana S Jain
- Department of Bioengineering, The University of Texas at Dallas, Richardson, TX 75080, USA
| | - Sareda T J Schramm
- Department of Biological Sciences, The University of Texas at Dallas, Richardson, TX 75080, USA
| | - Danyal A Siddiqui
- Department of Bioengineering, The University of Texas at Dallas, Richardson, TX 75080, USA
| | - Wenwen Huo
- Department of Biological Sciences, The University of Texas at Dallas, Richardson, TX 75080, USA
| | - Kelli L Palmer
- Department of Biological Sciences, The University of Texas at Dallas, Richardson, TX 75080, USA
| | | | - Danieli C Rodrigues
- Department of Bioengineering, The University of Texas at Dallas, Richardson, TX 75080, USA.
| |
Collapse
|
18
|
Abstract
Most would agree that the etiology of dental implant failure is related to oral biofilm. At present one group of scientists and clinicians feel that biofilm is solely responsible for bone loss around the devices. However, there is strong evidence that particles and ions of titanium released into the surrounding tissues by the action of biofilm and/or mechanical forces, a process termed metallosis, can be responsible for bone loss around some dental implants. These findings are reinforced by similar responses found around failed metal on metal joint prostheses. Both possible etiologies are discussed in detail in this commentary.
Collapse
|
19
|
Harrel SK, Wilson TG, Tunnell JC, Stenberg WV. Laser identification of residual microislands of calculus and their removal with chelation. J Periodontol 2020; 91:1562-1568. [DOI: 10.1002/jper.19-0698] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2019] [Revised: 02/24/2020] [Accepted: 04/01/2020] [Indexed: 11/11/2022]
Affiliation(s)
- Stephen K. Harrel
- Department of Periodontics Texas A&M University College of Dentistry Dallas TX
| | | | | | - William V. Stenberg
- Department of Biomedical Sciences Texas A&M University College of Dentistry Dallas TX
| |
Collapse
|
20
|
Wilson TG, Iyengar AJ, Hardikar W, Sood S, d'Udekem Y. Prevalence of hepatocellular carcinoma in the entire Fontan population of Australia and New Zealand. JTCVS Tech 2020; 2:128-130. [PMID: 34317777 PMCID: PMC8298915 DOI: 10.1016/j.xjtc.2020.03.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Revised: 01/09/2020] [Accepted: 03/08/2020] [Indexed: 11/27/2022] Open
Affiliation(s)
- Thomas G Wilson
- Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia.,Faculty of Medicine, Department of Paediatrics, The University of Melbourne, Melbourne, Australia
| | - Ajay J Iyengar
- Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia.,Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Australia
| | - Winita Hardikar
- Faculty of Medicine, Department of Paediatrics, The University of Melbourne, Melbourne, Australia.,Department of Gastroenterology, The Royal Children's Hospital, Melbourne, Australia
| | - Siddharth Sood
- Department of Gastroenterology and Hepatology, The Royal Melbourne Hospital, Melbourne, Australia
| | - Yves d'Udekem
- Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia.,Faculty of Medicine, Department of Paediatrics, The University of Melbourne, Melbourne, Australia.,Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Australia
| |
Collapse
|
21
|
Wilson TG, Robinson T, MacFarlane C, Spencer T, Herbert C, Wade L, Reed H, Braybrooke JP. Treating Brain Metastases from Breast Cancer: Outcomes after Stereotactic Radiosurgery. Clin Oncol (R Coll Radiol) 2020; 32:390-396. [PMID: 32131980 DOI: 10.1016/j.clon.2020.02.007] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2019] [Revised: 01/21/2020] [Accepted: 01/28/2020] [Indexed: 10/24/2022]
Abstract
AIMS Stereotactic radiosurgery (SRS) is an alternative to surgery or whole brain radiotherapy for the control of single or multiple brain metastases in patients with breast cancer. To date, there is no clear consensus on factors that might predict overall survival following SRS. The aim of this study was to assess the overall survival of breast cancer patients with brain metastases treated with SRS at a single centre and to examine the factors that might influence survival. MATERIALS AND METHODS A retrospective analysis of consecutive patients with breast cancer and brain metastases, considered suitable for SRS by the regional neuro-oncology multidisciplinary team. All patients were treated at a single National Health Service centre. RESULTS In total, 91 patients received SRS between 2013 and 2017, of whom 15 (16.5%) were alive at the time of analysis. The median overall survival post-SRS was 15.7 months (interquartile range 7.7-23.8 months) with no significant effect of age on survival (67 patients ≤ 65 years, 16.3 months; 26 patients > 65 years, 11.4 months, P = 0.129). The primary tumour receptor status was an important determinant of outcome: 31 oestrogen receptor positive (ER+)/human epidermal growth factor receptor 2 negative (HER2-) patients had a median overall survival of 13.8 months, 14 ER+/HER2+ patients had a median overall survival of 21.4 months, 30 ER-/HER2+ patients had a median overall survival of 20.4 months and 16 patients with triple negative breast cancer (TNBC) had a median overall survival of 8.5 months. A larger total volume of tumour treated (>10 cm3), but not the number of individual metastases treated, was associated with worse survival (P = 0.0002) in this series. Patients with stable extracranial disease at the time of SRS had improved overall survival compared with those with progressive extracranial disease (30 patients stable extracranial disease overall survival = 20.1 months versus 33 patients progressive extracranial disease overall survival = 11.4 months; P = 0.0011). Seventeen patients had no extracranial disease at the time of SRS, with a median overall survival of 13.1 months. CONCLUSIONS This single-centre series of consecutive patients with brain metastases from breast cancer, treated with SRS, had a similar overall survival compared with previous studies of SRS. TNBC and ER+/HER2- histology, metastatic volumes >10 cm3 and progressive extracranial disease at the time of SRS were associated with worse survival.
Collapse
Affiliation(s)
- T G Wilson
- Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
| | - T Robinson
- Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK; Population Health Sciences, University of Bristol, Bristol, UK
| | - C MacFarlane
- University Hospitals Southampton NHS Foundation Trust, Southampton, UK
| | - T Spencer
- Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
| | - C Herbert
- Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
| | - L Wade
- Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
| | - H Reed
- Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
| | - J P Braybrooke
- Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
| |
Collapse
|
22
|
Khuong JN, Wilson TG, Grigg LE, Bullock A, Celermajer D, Disney P, Wijesekera VA, Hornung T, Zannino D, Iyengar AJ, d'Udekem Y. Fontan-associated nephropathy: Predictors and outcomes. Int J Cardiol 2020; 306:73-77. [PMID: 31955974 DOI: 10.1016/j.ijcard.2020.01.014] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/19/2019] [Accepted: 01/08/2020] [Indexed: 01/12/2023]
Abstract
BACKGROUND Nephropathy is a known complication of the Fontan circulation, but its determinants have not been identified and patient outcomes are also still unknown. METHODS The Australia and New Zealand Fontan Registry was used to identify those who underwent Fontan operation before and survived beyond 16-years-old with an intact Fontan circulation. Serum creatinine values were collected for each patient between 16 and 25 years and at recent follow-up. The Modification of Diet in Renal Disease (MDRD) equation was used to calculate eGFR. Patient outcomes were obtained from the Registry. Fontan failure was defined as death, transplantation, plastic bronchitis, protein losing enteropathy, Fontan takedown and NYHA class III-IV. RESULTS Serum creatinine measurements were available for 328 patients. Renal dysfunction was defined as eGFR <90 mL/min/1.72m2. Renal dysfunction was present in 67/328 (20%) and 3/328 (1%) patients had an eGFR <60 mL/min/1.72m2. The 10-year survival and 10-year freedom from death and transplantation were the same, 96% (95% CI: 0.9-1) for those with renal dysfunction, and 89% (0.83-0.95; p = 0.1) and 87% (95% CI: 0.81-0.94; p = 0.05) for patients without dysfunction. The 10-year freedom from failure were also similar, 83% (95% CI: 0.70-0.97) for those without renal dysfunction vs 80% (95% CI: 0.74-0.89; p = 0.84). There was no change in mean eGFR for the renal dysfunction group over a mean of 8 ± 5.5 years. CONCLUSION By the time they reach adulthood, 20% of patients with a Fontan circulation have renal dysfunction by eGFR calculation. Over the course of one decade, Fontan-associated nephropathy appears well tolerated.
Collapse
Affiliation(s)
- Jacqueline Nguyen Khuong
- Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Australia
| | - Thomas G Wilson
- Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Australia
| | - Leeanne E Grigg
- Department of Cardiology, The Royal Melbourne Hospital, Melbourne, Australia
| | - Andrew Bullock
- Children's Cardiac Centre, Princess Margaret Hospital for Children, Perth, Australia
| | - David Celermajer
- Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia
| | - Patrick Disney
- Department of Cardiology, Women's and Children's Hospital, Adelaide, Australia
| | | | - Tim Hornung
- Green Lane Paediatric and Congenital Cardiac Service, Auckland District Health Board, Auckland, New Zealand
| | - Diana Zannino
- Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia
| | - Ajay J Iyengar
- Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Australia; Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Australia
| | - Yves d'Udekem
- Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Australia; Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Australia.
| |
Collapse
|
23
|
Wilson TG, Hanna A, Recknagel J, Pruetz BL, Baschnagel AM, Wilson GD. Prognostic significance of MTOR expression in HPV positive and negative head and neck cancers treated by chemoradiation. Head Neck 2019; 42:153-162. [PMID: 31657099 DOI: 10.1002/hed.25983] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2019] [Revised: 08/29/2019] [Accepted: 09/17/2019] [Indexed: 12/26/2022] Open
Abstract
BACKGROUND The mechanistic target of rapamycin (MTOR) plays a key role in regulating cell growth and metabolism and is commonly overexpressed in head and neck cancer (HNSCC). This study investigated the association of MTOR with clinical outcome in human papilloma virus (HPV) positive and negative HNSCC patients treated by chemoradiation. METHODS A tissue microarray (TMA) consisting of cores from 109 HNSCC patients treated by definitive chemoradiation was constructed and stained with antibodies against p16 and MTOR and expression correlated with clinicopathological features and clinical outcome. RESULTS MTOR varied widely between tumor cores and was not associated with HPV status or clinicopathological features. There was a positive correlation with pre-treatment FDG uptake. (P = .01). In HPV negative patients, MTOR predicted for shorter locoregional control (P = .02), diseases free survival (P = .02), and overall survival (P = .04). MTOR expression was not associated with outcome in HPV positive patients. CONCLUSIONS Prognostic significance of MTOR expression depends on HPV status.
Collapse
Affiliation(s)
- Thomas G Wilson
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan
| | - Alaa Hanna
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan
| | - Johnathon Recknagel
- Oakland University William Beaumont School of Medicine, Oakland University, Rochester, Michigan
| | - Barbara L Pruetz
- Beaumont BioBank, William Beaumont Hospital, Royal Oak, Michigan
| | - Andrew M Baschnagel
- Department of Human Oncology, University of Wisconsin Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin
| | - George D Wilson
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan
| |
Collapse
|
24
|
Wilson TG, d'Udekem Y, Winlaw DS, Cordina RL, Ayer J, Gentles TL, Weintraub RG, Grigg LE, Cheung M, Cain TM, Rao P, Verrall C, Plessis KD, Rice K, Iyengar AJ. Creatinine-based estimation of glomerular filtration rate in patients with a Fontan circulation. CONGENIT HEART DIS 2019; 14:454-463. [PMID: 30664330 DOI: 10.1111/chd.12746] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/28/2018] [Revised: 11/17/2018] [Accepted: 01/03/2019] [Indexed: 11/30/2022]
Abstract
BACKGROUND Patients with a Fontan circulation are at risk of renal dysfunction. We analyzed cross-sectional data in pediatric and adult Fontan patients in order to assess the accuracy of commonly used serum creatinine-based methods in estimating glomerular filtration rate (GFR). METHODS A total of 124 Fontan patients (58 children, 66 adults) were enrolled across three study centers. Measurement of GFR (mGFR) using in vivo 99m Tc-DTPA clearance was performed. Various serum creatinine-based equations were used to calculate estimated GFR (eGFR). RESULTS Mean mGFR was 108 ± 28 mL/min/1.73 m2 in children and 92 ± 20 mL/min/1.73 m2 in adults. Fourteen children (25%) and 28 adults (45%) had an mGFR <90 mL/min/1.73 m2 . There was no significant correlation between mGFR and eGFR (Schwartz) in children (r = 0.22, P = .1), which substantially overestimated mGFR (bias 50.8, 95%CI: 41.1-60.5 mL/min/1.73 m2 , P < .0001). The Bedside Schwartz equation also performed poorly in the children (r = 0.08, P = .5; bias 5.9, 95%CI: -2.9-14.6 mL/min/1.73 m2 , P < .0001). There was a strong correlation between mGFR and both eGFR (CKD-EPI) and eGFR (MDRD) in adults (r = 0.67, P < .0001 in both cases), however, both methods overestimated mGFR (eGFR(CKD-EPI):bias 23.8, 95%CI: 20-27.6 mL/min/1.73 m2 , P < .0001; eGFR (MDRD):bias 16.1, 95%CI: 11.8-20.4 mL/min/1.73 m2 , P < .0001). None of the children with an mGFR <90 mL/min/1.73 m2 had an eGFR (Schwartz) <90 mL/min/1.73 m2 . Sensitivity and specificity of eGFR (CKD-EPI) and eGFR (MDRD) for mGFR <90 mL/min/1.73 m2 in adults were 25% and 92% and 39% and 100%, respectively. CONCLUSIONS This study identifies the unreliability of using creatinine-based equations to estimate GFR in children with a Fontan circulation. The accuracy of formulas incorporating cystatin C should be further investigated and may aid noninvasive surveillance of renal function in this population.
Collapse
Affiliation(s)
- Thomas G Wilson
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia.,Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Victoria, Australia
| | - Yves d'Udekem
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia.,Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.,Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Victoria, Australia
| | - David S Winlaw
- The Heart Centre for Children, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.,Department of Paediatrics, University of Sydney, Sydney, New South Wales, Australia
| | - Rachael L Cordina
- Department of Paediatrics, University of Sydney, Sydney, New South Wales, Australia.,Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
| | - Julian Ayer
- The Heart Centre for Children, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.,Department of Paediatrics, University of Sydney, Sydney, New South Wales, Australia
| | - Thomas L Gentles
- Greenlane Paediatric and Congenital Cardiac Service, Starship Children's Hospital, Auckland, New Zealand
| | - Robert G Weintraub
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia.,Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.,Department of Cardiology, The Royal Children's Hospital, Melbourne, Victoria, Australia
| | - Leeanne E Grigg
- Department of Cardiology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia
| | - Michael Cheung
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia.,Department of Cardiology, The Royal Children's Hospital, Melbourne, Victoria, Australia
| | - Timothy M Cain
- Medical Imaging Department, The Royal Children's Hospital, Melbourne, Victoria, Australia
| | - Padma Rao
- Medical Imaging Department, The Royal Children's Hospital, Melbourne, Victoria, Australia
| | - Charlotte Verrall
- The Heart Centre for Children, The Children's Hospital at Westmead, Sydney, New South Wales, Australia
| | - Karin Du Plessis
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
| | - Kathryn Rice
- Greenlane Paediatric and Congenital Cardiac Service, Starship Children's Hospital, Auckland, New Zealand
| | - Ajay J Iyengar
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia.,Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Victoria, Australia
| |
Collapse
|
25
|
Sridhar S, Wang F, Wilson TG, Palmer K, Valderrama P, Rodrigues DC. The role of bacterial biofilm and mechanical forces in modulating dental implant failures. J Mech Behav Biomed Mater 2019; 92:118-127. [PMID: 30685725 DOI: 10.1016/j.jmbbm.2019.01.012] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2018] [Revised: 12/27/2018] [Accepted: 01/16/2019] [Indexed: 12/20/2022]
Abstract
Currently many assume that bacteria are the primary etiological factor associated with failure of titanium dental implants. However, emerging data indicates a possible role for mechanical forces in implant failure. This study is based on the hypothesis that the synergistic effect of mechanical forces and bacterial biofilm can lead to surface damage resulting in in vivo release of metallic particles. The primary aim of the study was to develop a dynamic fatigue test method for dental implants immersed in wet environments such as; (i) 0.01 M phosphate buffer saline (PBS); (ii) lactic acid (pH = 5); (iii) bacterial polyculture. Four dental implants each were subjected to fatigue loading from 45 N to 450 N at 4 Hz for 2 million cycles while immersed in (i) PBS (negative control); (ii) bacterial culture (test); and (iii) lactic acid (positive control). Post-testing, optical microscopy, x-ray photoelectron spectroscopy, and electrochemical corrosion tests were performed to evaluate the surface morphology, chemistry, and potential, respectively, of titanium implants. Post-testing, surface discoloration was evident in all three groups. However, the surface damage was further established in XPS analyses of test specimens, which showed that the interplay of bacterial biofilm and mechanical forces resulted in thinning of the TiO2. Lower corrosion potential (Ecorr) of the test specimens compared to positive and negative controls also illustrated damage to the oxide layer. However, other electrochemical parameters such as linear polarization resistance (LPR) and corrosion rate (CR) were comparable among the groups indicating the corrosion resistance post-testing. The synergistic effect of cyclic occlusal loading and bacteria biofilm could negatively affect the surface of titanium dental implants.
Collapse
Affiliation(s)
- Sathyanarayanan Sridhar
- Department of Bioengineering, University of Texas at Dallas, Richardson, TX 75080, United States.
| | - Frederick Wang
- Department of Bioengineering, University of Texas at Dallas, Richardson, TX 75080, United States.
| | - Thomas G Wilson
- Private Practice of Periodontics, Dallas, TX 75231, United States.
| | - Kelli Palmer
- Department of Biological Sciences, University of Texas at Dallas, Richardson, TX 75080, United States.
| | - Pilar Valderrama
- Private Practice of Periodontics, Dallas, TX 75231, United States.
| | - Danieli C Rodrigues
- Department of Bioengineering, University of Texas at Dallas, Richardson, TX 75080, United States.
| |
Collapse
|
26
|
Wilson TG. A New Minimally Invasive Approach for Treating Peri‐Implantitis. Clin Adv Periodontics 2019; 9:59-63. [DOI: 10.1002/cap.10052] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2018] [Accepted: 07/30/2018] [Indexed: 11/11/2022]
|
27
|
Harrel SK, Wilson TG, Pandya M, Diekwisch TGH. Titanium particles generated during ultrasonic scaling of implants. J Periodontol 2018; 90:241-246. [PMID: 30312471 DOI: 10.1002/jper.18-0230] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2018] [Revised: 06/23/2018] [Accepted: 07/16/2018] [Indexed: 11/07/2022]
Abstract
BACKGROUND There is growing concern that titanium particles may play a role in peri-implant breakdown. Ultrasonic scalers are routinely used in the debridement of peri-implant lesions. This in vitro study is designed to evaluate if titanium particles are produced when an ultrasonic scaler is used on an implant. METHODS New sandblasted, large grit, acid etched (SLA) coated implants were subjected to ultrasonic scaling with stainless steel, titanium, and PEEK plastic tips. The implants were placed in a holding device and the ultrasonic scaler was positioned on the SLA surface under 25 grams of pressure. The implants were subjected to 30 scaling motions. The ultrasonic coolant water was collected and the number of metallic particles were counted under a light microscope. The particles were confirmed to be titanium via elemental analysis. The implants were visually evaluated for damage to the SLA coating. RESULTS No metallic particles were detected in the water supplied to the ultrasonic scalers (passive control). Metallic particles were detected when implants were subjected to the ultrasonic coolant water only without the scaler tip touching the implant (active control). All implants that were scaled produced metallic particles and showed easily detectable damage to the SLA layer. CONCLUSIONS All ultrasonic scaling caused the production of titanium particles and caused damage to the SLA coating of the implant. Ultrasonic scalers should be used with great caution in the treatment of peri-implant conditions and care should be taken to not touch the SLA surface of the implant.
Collapse
Affiliation(s)
- Stephen K Harrel
- Periodontal Department, Texas A&M College of Dentistry, Dallas, TX
| | | | - Mirali Pandya
- Periodontal Department, Texas A&M College of Dentistry, Dallas, TX
| | | |
Collapse
|
28
|
Feine J, Abou‐Ayash S, Al Mardini M, Santana RB, Bjelke‐Holtermann T, Bornstein MM, Braegger U, Cao O, Cordaro L, Eycken D, Fillion M, Gebran G, Huynh‐Ba G, Joda T, Levine R, Mattheos N, Oates TW, Abd‐Ul‐Salam H, Santosa R, Shahdad S, Storelli S, Sykaras N, Treviño Santos A, Stephanie Webersberger U, Williams MAH, Wilson TG, Wismeijer D, Wittneben J, Yao CJ, Zubiria JPV. Group 3 ITI Consensus Report: Patient‐reported outcome measures associated with implant dentistry. Clin Oral Implants Res 2018; 29 Suppl 16:270-275. [DOI: 10.1111/clr.13299] [Citation(s) in RCA: 44] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2018] [Accepted: 05/26/2018] [Indexed: 11/28/2022]
Affiliation(s)
- Jocelyne Feine
- Oral Health and SocietyFaculty of DentistryMcGill University Montreal QC Canada
| | - Samir Abou‐Ayash
- Department of Reconstructive Dentistry and GerodontologySchool of Dental MedicineUniversity of Bern Bern Switzerland
| | - Majd Al Mardini
- Department of Dentistry and Maxillofacial ProstheticsPrincess Margaret Hospital Toronto ON Canada
- Private PracticeAlmardini Prosthodontics Hamilton ON Canada
| | - Ronaldo Barcelllos Santana
- Department of Reconstructive Dentistry and GerodontologySchool of Dental MedicineUniversity of Bern Bern Switzerland
| | | | - Michael M. Bornstein
- Implant DentistryFaculty of DentistryThe University of Hong Kong Hong Kong China
| | - Urs Braegger
- Department of Reconstructive Dentistry and GerodontologySchool of Dental MedicineUniversity of Bern Bern Switzerland
| | - Olivia Cao
- Implant DentistryFaculty of DentistryThe University of Hong Kong Hong Kong China
| | - Luca Cordaro
- Department of Periodontology and ProsthodonticsEastman Dental HospitalUniversity Policlinic Umberto I Rome Italy
| | | | - Mathieu Fillion
- Private PracticeDom'implant Formation Clermont‐Ferrand France
| | - Georges Gebran
- Department of Reconstructive Dentistry and GerodontologySchool of Dental MedicineUniversity of Bern Bern Switzerland
| | - Guy Huynh‐Ba
- PeriodonticsThe University of Texas Health Science Center at San Antonio – UTHSCSA San Antonio Texas
| | - Tim Joda
- Department of Reconstructive DentistryUniversity Center for Dental Medicine Basel UZBUniversity of Basel Basel Switzerland
- Department of Reconstructive Dentistry and GerodontologySchool of Dental MedicineUniversity of Bern Bern Switzerland
| | - Robert Levine
- Pennsylvania Center for Dental Implants & Periodontics Philadelphia Pennsylvania
| | - Nikos Mattheos
- Implant DentistryFaculty of DentistryThe University of Hong Kong Hong Kong China
| | - Thomas W. Oates
- Department of Advanced Oral Sciences & TherapeuticsSchool of DentistryUniversity of Maryland Baltimore Maryland
| | - Hani Abd‐Ul‐Salam
- Faculty of Dentistry, Oral & Maxillofacial SurgeryUniversity of Sharjah Sharjah United Arab Emirates
- Faculty of DentistryMcGill University Montreal QC Canada
- McGill University Continuing Dental Education for the Middle East & North Africa Montreal QC Canada
| | - Robert Santosa
- Private practiceMacquarie Central Prosthodontics Sydney NSW Australia
| | - Shakeel Shahdad
- Department of Restorative Dentistry, Barts and The London School of Medicine and DentistryQueen Mary University of London London UK
| | - Stefano Storelli
- Department of Biomedical, Surgical and Dental SciencesUniversity of Milan Milan Italy
| | - Nikitas Sykaras
- Department of Removable ProsthodonticsDental SchoolNational and Kapodistrian University of Athens Athens Greece
| | - Alejandro Treviño Santos
- Postdoctoral and Research DivisionFaculty of DentistryNational Autonomous University of Mexico, UNAM Mexico City Mexico
| | | | - Mary Ann H. Williams
- Health Science & Human Services LibraryUniversity of Maryland Baltimore Maryland
| | | | - Daniel Wismeijer
- Department of Oral Implantology and Prosthetic DentistryACTA (Academic Center for Dentistry Amsterdam Free University) Amsterdam The Netherlands
| | - Julia‐Gabriela Wittneben
- Department of Reconstructive Dentistry and GerodontologySchool of Dental MedicineUniversity of Bern Bern Switzerland
- Department of Restorative Dentistry and Biomaterials SciencesHarvard School of Dental Medicine Boston Massachusetts
| | - Coral Jie Yao
- Implant DentistryFaculty of DentistryThe University of Hong Kong Hong Kong China
| | | |
Collapse
|
29
|
Siddiqui DA, Guida L, Sridhar S, Valderrama P, Wilson TG, Rodrigues DC. Evaluation of oral microbial corrosion on the surface degradation of dental implant materials. J Periodontol 2018; 90:72-81. [DOI: 10.1002/jper.18-0110] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2018] [Revised: 05/17/2018] [Accepted: 05/27/2018] [Indexed: 12/20/2022]
Affiliation(s)
- Danyal A. Siddiqui
- Department of Bioengineering; The University of Texas at Dallas; Richardson TX
| | - Lidia Guida
- Department of Bioengineering; The University of Texas at Dallas; Richardson TX
| | | | | | | | | |
Collapse
|
30
|
Blas K, Wilson TG, Tonlaar N, Galoforo S, Hana A, Marples B, Wilson GD. Dual blockade of PI3K and MEK in combination with radiation in head and neck cancer. Clin Transl Radiat Oncol 2018; 11:1-10. [PMID: 30014041 PMCID: PMC6019866 DOI: 10.1016/j.ctro.2018.04.003] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2018] [Revised: 04/16/2018] [Accepted: 04/20/2018] [Indexed: 02/07/2023] Open
Abstract
Background and purpose In this study we have combined fractionated radiation treatment (RT) with two molecular targeted agents active against key deregulated signaling pathways in head and neck cancer. Materials and methods We used two molecularly characterized, low passage HNSCC cell lines of differing biological characteristics to study the effects of binimetinib and buparlisib in combination with radiation in vitro and in vivo. Results Buparlisib was active against both cell lines in vitro whereas binimetinib was more toxic to UT-SCC-14. Neither agent modified radiation sensitivity in vitro. Buparlisib significantly inhibited growth of UT-SSC-15 alone or in combination with RT but was ineffective in UT-SCC-14. Binimetinib did cause a significant delay with RT in UT-SCC-14 and it significantly reduced growth of the UT-SCC-15 tumors both alone and with RT. The tri-modality treatment was not as effective as RT with a single effective agent. Conclusions No significant benefit was gained by the combined use of the two agents with RT even though each was efficacious when used alone.
Collapse
Affiliation(s)
- Kevin Blas
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States
| | - Thomas G Wilson
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States
| | - Nathan Tonlaar
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States
| | - Sandra Galoforo
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States
| | - Alaa Hana
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States
| | - Brian Marples
- Department of Radiation Oncology, Miller School of Medicine, University of Miami, Miami, FL, United States
| | - George D Wilson
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.,Beaumont BioBank, William Beaumont Hospital, Royal Oak, MI, United States
| |
Collapse
|
31
|
Wheelis SE, Wilson TG, Valderrama P, Rodrigues DC. Surface characterization of titanium implant healing abutments before and after placement. Clin Implant Dent Relat Res 2017; 20:180-190. [PMID: 29214721 DOI: 10.1111/cid.12566] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2017] [Revised: 11/09/2017] [Accepted: 11/10/2017] [Indexed: 01/04/2023]
Abstract
BACKGROUND Implant healing abutments (IHA) have a vital role in soft tissue healing after implant placement. Although there is thorough investigation on the implant surface, little is known about the effects potentially damaging oral conditions impose on healing abutments. PURPOSE To characterize the surface of titanium healing abutments before and after clinical placement to understand the effects of the oral environment and time on the device surface. MATERIALS AND METHODS Ten regular Straumann IHA were subjected to characterization pre and postplacement to elucidate the effects of the oral environment on device surfaces. Changes in surface crystallinity, morphology, and elemental composition were monitored with Raman spectroscopy, scanning electron microscopy, optical microscopy, and x-ray photoelectron spectroscopy, respectively. In addition, corrosion rate and polarization resistance were obtained to assess electrochemical device stability after placement. RESULTS Control analysis indicated the titanium oxide of IHAs was thicker than natural commercially pure titanium and had the structure of crystalline anatase. After removal, the abutments possessed large amounts of biological debris, visible scratches, and discoloration sparsely on the surface. Spectroscopic analysis revealed the titanium oxide on the surface of IHAs was structurally unchanged, with crystalline titanium dioxide still present on the surface. Electrochemical results revealed that implanted healing abutments possessed a significantly higher corrosion rate than controls (change in corrosion rate = 2.34 ± 0.58 nm/year). CONCLUSIONS Healing abutments were stable in the oral environment due to the chemical stability of the oxide, and were likely subjected to abrasions from unintentional loading and oral hygiene techniques.
Collapse
Affiliation(s)
- Sutton E Wheelis
- Deparment of Bioengineering, The University of Texas at Dallas, Richardson, Texas, USA
| | - Thomas G Wilson
- Deparment of Periodontics and Dental Implants, North Dallas Dental Health, Dallas, Texas, USA
| | - Pilar Valderrama
- Deparment of Periodontics and Dental Implants, North Dallas Dental Health, Dallas, Texas, USA
| | - Danieli C Rodrigues
- Deparment of Bioengineering, The University of Texas at Dallas, Richardson, Texas, USA
| |
Collapse
|
32
|
Abstract
The most common approach to lessen treatment times is by decreasing the healing period during which osseointegration is established. Implant design parameters such as implant surface, primary stability, thread configuration, body shape, and the type of bone have to be considered to obtain this objective. The relationship that exists between these components will define the initial stability of the implant. It is believed implant sites using a tapered design and surface modification can increase the primary stability in low-density bone. Furthermore, recent experimental preclinical work has shown the possibility of attaining primary stability of immediately loaded, tapered dental implants without compromising healing and rapid bone formation while minimizing the implant stability loss at compression sites. This may be of singular importance with immediate/early functional loading of single implants placed in poor-quality bone. The selection of an implant that will provide adequate stability in bone of poor quality is important. A tapered-screw implant design will provide adequate stability because it creates pressure on cortical bone in areas of reduced bone quality. Building on the success of traditional tapered implant therapy, newer tapered implant designs should aim to maximize the clinical outcome by implementing new technologies with adapted clinical workflows.
Collapse
Affiliation(s)
| | | | - R Trushkowsky
- New York University College of Dentistry, Department of Cariology and Comprehensive Care, New York City, NY, USA
| | - M Dard
- New York University College of Dentistry, Department of Periodontology and Implant Dentistry, New York City, NY, USA Institut Straumann, Basel, Switzerland
| |
Collapse
|
33
|
Wilson TG, Shi WY, Iyengar AJ, Winlaw DS, Cordina RL, Wheaton GR, Bullock A, Gentles TL, Weintraub RG, Justo RN, Grigg LE, Radford DJ, d'Udekem Y. Twenty-Five Year Outcomes of the Lateral Tunnel Fontan Procedure. Semin Thorac Cardiovasc Surg 2017; 29:347-353. [PMID: 29195575 DOI: 10.1053/j.semtcvs.2017.06.002] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/01/2017] [Indexed: 11/11/2022]
Abstract
The objective of this study was to characterize late outcomes of the lateral tunnel (LT) Fontan procedure. The outcomes of all patients who underwent an LT Fontan procedure in Australia and in New Zealand were analyzed. Original files were reviewed and outcomes data were obtained through a binational registry. Between 1980 and 2014, a total of 301 patients underwent an LT Fontan procedure across 6 major centers. There were 13 hospital mortalities, 21 late deaths, 8 Fontan conversions and revisions, 8 Fontan takedowns, and 4 heart transplantations. Overall survival at 15 and 25 years was 90% (95% confidence interval [CI]: 86%-93%) and 80% (95% CI: 69%-91%), respectively. Protein-losing enteropathy or plastic bronchitis was observed in 14 patients (5%). Freedom from late failure at 15 and 25 years was 88% (95% CI: 84%-92%) and 82% (95% CI: 76%-87%), respectively. Independent predictors of late Fontan failure were prolonged pleural effusions post Fontan operations (hazard ratio [HR] 3.06, 1.05-8.95, P = 0.041), age >7 years at Fontan (vs 3-5 years, HR 9.7, 2.46-38.21, P = 0.001) and development of supraventricular tachycardia (HR 4.67, 2.07-10.58, P < 0.001). Freedom from tachy- or bradyarrhythmias at 10 and 20 years was 87% (95% CI: 83%-91%) and 72% (95% CI: 66%-79%), respectively. Thromboembolic events occurred in 45 patients (16%, 26 strokes), and freedom from symptomatic thromboembolism at 10 and 20 years was 93% (95% CI: 89%-96%) and 80% (95% CI: 74%-86%), respectively. Over a 25-year period, the LT technique has achieved excellent late survival. As this population ages, it is at an increasing risk of failure and adverse events. We are likely to see an increasing proportion requiring heart transplantation and late reintervention.
Collapse
Affiliation(s)
- Thomas G Wilson
- Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Victoria, Australia; Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Victoria, Australia
| | - William Y Shi
- Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Victoria, Australia; Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Victoria, Australia
| | - Ajay J Iyengar
- Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Victoria, Australia; Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Victoria, Australia
| | - David S Winlaw
- The Heart Centre for Children, The Children's Hospital at Westmead, Sydney, New South Wales, Australia; Department of Paediatrics, University of Sydney, Sydney, New South Wales, Australia
| | - Rachael L Cordina
- Department of Paediatrics, University of Sydney, Sydney, New South Wales, Australia; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
| | - Gavin R Wheaton
- Department of Cardiology, Women's and Children's Hospital, Adelaide, South Australia, Australia
| | - Andrew Bullock
- Children's Cardiac Centre, Princess Margaret Hospital for Children, Perth, Western Australia, Australia
| | - Thomas L Gentles
- Greenlane Paediatric and Congenital Cardiac Service, Starship Children's Hospital, Auckland, New Zealand
| | - Robert G Weintraub
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Department of Cardiology, Royal Children's Hospital, Melbourne, Victoria, Australia
| | - Robert N Justo
- Queensland Paediatric Cardiac Service, Lady Cilento Children's Hospital, Brisbane, Queensland, Australia
| | - Leeanne E Grigg
- Department of Cardiology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia
| | - Dorothy J Radford
- Adult Congenital Heart Unit, The Prince Charles Hospital, Brisbane, Queensland, Australia; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia
| | - Yves d'Udekem
- Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Victoria, Australia; Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
| | | |
Collapse
|
34
|
Johnson MD, Stone B, Thibodeau BJ, Baschnagel AM, Galoforo S, Fortier LE, Ketelsen B, Ahmed S, Kelley Z, Hana A, Wilson TG, Robertson JM, Jury RP, Wilson GD. The significance of Trk receptors in pancreatic cancer. Tumour Biol 2017; 39:1010428317692256. [PMID: 28218045 DOI: 10.1177/1010428317692256] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
This study investigated the Trk receptor family as a therapeutic target in pancreatic ductal adenocarcinoma and assessed their prognostic significance. Global gene expression analysis was investigated in prospectively collected pancreatic ductal adenocarcinomas that had either undergone neoadjuvant chemoradiation or were treated by surgery. PANC-1 and MIA-PaCa-2 cell lines were investigated to establish whether fractionated radiation altered expression of four neuroendocrine genes and whether this resulted in subsequent changes in radiosensitivity. A specific inhibitor of TrkA, B, and C, AstraZeneca 1332, was investigated in vitro and in vivo in combination with radiation. A tissue microarray was constructed from 77 pancreatic ductal adenocarcinoma patients who had undergone neoadjuvant chemoradiation and the Trk receptor, and neurogenic differentiation 1 expression was assessed and correlated with overall survival. A total of 99 genes were identified that were differentially expressed in the chemoradiation patients with neuroendocrine genes and pathways, in particular the neurogenic differentiation 1 and Trk receptor family, being prominent. Fractionated radiation upregulated the expression of neuroendocrine genes, and AstraZeneca 1332 treatment in vitro enhanced radiosensitivity. No added effect of AstraZeneca 1332 was observed in vivo. Trk receptor expression varied between isoforms but did not correlate significantly with clinical outcome. Radiation treatment upregulated neuroendocrine gene expression but the Trk receptor family does not appear to be a promising treatment target.
Collapse
Affiliation(s)
- Matthew D Johnson
- 1 Department of Radiation Oncology, William Beaumont Hospital, Beaumont Health System, Royal Oak, MI, USA
| | - Brandon Stone
- 1 Department of Radiation Oncology, William Beaumont Hospital, Beaumont Health System, Royal Oak, MI, USA
| | - Bryan J Thibodeau
- 2 Beaumont BioBank, William Beaumont Hospital, Beaumont Health System, Royal Oak, MI, USA
| | - Andrew M Baschnagel
- 3 Department of Human Oncology, University of Wisconsin-Madison, Madison, WI, USA
| | - Sandra Galoforo
- 1 Department of Radiation Oncology, William Beaumont Hospital, Beaumont Health System, Royal Oak, MI, USA
| | - Laura E Fortier
- 2 Beaumont BioBank, William Beaumont Hospital, Beaumont Health System, Royal Oak, MI, USA
| | - Billie Ketelsen
- 2 Beaumont BioBank, William Beaumont Hospital, Beaumont Health System, Royal Oak, MI, USA
| | - Samreen Ahmed
- 2 Beaumont BioBank, William Beaumont Hospital, Beaumont Health System, Royal Oak, MI, USA
| | - Zakiya Kelley
- 2 Beaumont BioBank, William Beaumont Hospital, Beaumont Health System, Royal Oak, MI, USA
| | - Alaa Hana
- 1 Department of Radiation Oncology, William Beaumont Hospital, Beaumont Health System, Royal Oak, MI, USA
| | - Thomas G Wilson
- 1 Department of Radiation Oncology, William Beaumont Hospital, Beaumont Health System, Royal Oak, MI, USA
| | - John M Robertson
- 1 Department of Radiation Oncology, William Beaumont Hospital, Beaumont Health System, Royal Oak, MI, USA
| | - Robert P Jury
- 4 Department of General Surgery, William Beaumont Hospital, Beaumont Health System, Royal Oak, MI, USA
| | - George D Wilson
- 1 Department of Radiation Oncology, William Beaumont Hospital, Beaumont Health System, Royal Oak, MI, USA
| |
Collapse
|
35
|
|
36
|
Wilson TG. Letter to the Editor: Re: Investigation of the Association Between Cement Retention and Prevalent Peri-Implant Diseases: A Cross-Sectional Study. J Periodontol 2016; 87:998-9. [DOI: 10.1902/jop.2016.160182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
37
|
Wilson TG, Jenkins P, Hoschtitzky A, McCabe M. An extremely rare case of a high-grade pleomorphic cardiac sarcoma and likely cerebral metastasis in a young patient. Ecancermedicalscience 2016; 10:664. [PMID: 27594909 PMCID: PMC4990053 DOI: 10.3332/ecancer.2016.664] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2016] [Indexed: 11/26/2022] Open
Abstract
To date, there have been less than a 100 confirmed case reports of primary cardiac malignant fibrous histiocytomas, a rare form of sarcoma. In this report, we discuss the case of a 15-year-old girl who initially presented with a histiocytic cerebral sarcoma that was treated with aggressive resection and chemotherapy. Three years later, the same patient developed increasing shortness of breath and was found to have a high-grade pleomorphic undifferentiated cardiac sarcoma that likely represents the primary tumour from which the cerebral lesion metastasised. This represents an extremely unique case; in 2010, a research group in Germany claimed the very first description of a true cardiac sarcoma with brain metastasis [1]. However, even as far back as 1960, there were three case reports [2] and more extensive sarcoma studies recently have revealed further cases [3]. Nevertheless, there have probably been less than 10 cases in the literature up until this point.
Collapse
Affiliation(s)
- T G Wilson
- Central Manchester Foundation Trust, Oxford Rd, Manchester M13 9WL, UK
| | - P Jenkins
- Central Manchester Foundation Trust, Oxford Rd, Manchester M13 9WL, UK
| | - A Hoschtitzky
- Central Manchester Foundation Trust, Oxford Rd, Manchester M13 9WL, UK
| | - M McCabe
- Central Manchester Foundation Trust, Oxford Rd, Manchester M13 9WL, UK
| |
Collapse
|
38
|
Sridhar S, Abidi Z, Wilson TG, Valderrama P, Wadhwani C, Palmer K, Rodrigues DC. In Vitro Evaluation of the Effects of Multiple Oral Factors on Dental Implants Surfaces. J ORAL IMPLANTOL 2016; 42:248-57. [DOI: 10.1563/aaid-joi-d-15-00165] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Presence of metal ions and debris resulting from corrosion processes of dental implants in vivo can elicit adverse tissue reactions, possibly leading to peri-implant bone loss and eventually implant failure. This study hypothesized that the synergistic effects of bacterial biofilm and micromotion can cause corrosion of dental implants and release of metal ions in vivo. The goal is to simulate the oral environment where an implant will be exposed to a combination of acidic electrochemical environment and mechanical forces. Four conditions were developed to understand the individual and synergistic effects of mechanical forces and bacterial biofilm on the surface of dental implants; In condition 1, it was found that torsional forces during surgical insertion did not generate wear particle debris or metal ions. In condition 2, fatigue tests were performed in a wet environment to evaluate the effect of cyclic occlusal forces. The mechanical forces applied on the implants were able to cause implant fracture as well as surface corrosion features such as discoloration, delamination, and fatigue cracks. Immersion testing (condition 3) showed that bacteria (Streptococcus mutans) were able to create an acidic condition that triggered surface damage such as discoloration, rusting, and pitting. A novel testing setup was developed to understand the conjoint effects of micromotion and bacterial biofilm (condition 4). Surface damage initiated by acidic condition due to bacteria (condition 3), can be accelerated in tandem with mechanical forces through fretting-crevice corrosion. Permanent damage to surface layers can affect osseointegration and deposition of metal ions in the surrounding tissues can trigger inflammation.
Collapse
Affiliation(s)
| | - Zain Abidi
- Department of Biological Sciences, University of Texas at Dallas, Richardson, Texas
| | | | | | - Chandur Wadhwani
- Department of Restorative Dentistry, University of Washington, Seattle, Wash
| | - Kelli Palmer
- Department of Biological Sciences, University of Texas at Dallas, Richardson, Texas
| | | |
Collapse
|
39
|
Meyer K, Krueger SA, Kane JL, Wilson TG, Hanna A, Dabjan M, Hege KM, Wilson GD, Grills I, Marples B. Pulsed Radiation Therapy With Concurrent Cisplatin Results in Superior Tumor Growth Delay in a Head and Neck Squamous Cell Carcinoma Murine Model. Int J Radiat Oncol Biol Phys 2016; 96:161-9. [PMID: 27511853 DOI: 10.1016/j.ijrobp.2016.04.031] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2016] [Revised: 04/13/2016] [Accepted: 04/30/2016] [Indexed: 01/09/2023]
Abstract
PURPOSE To assess the efficacy of 3-week schedules of low-dose pulsed radiation treatment (PRT) and standard radiation therapy (SRT), with concurrent cisplatin (CDDP) in a head and neck squamous cell carcinoma xenograft model. METHODS AND MATERIALS Subcutaneous UT-SCC-14 tumors were established in athymic NIH III HO female mice. A total of 30 Gy was administered as 2 Gy/d, 5 d/wk for 3 weeks, either by PRT (10 × 0.2 Gy/d, with a 3-minute break between each 0.2-Gy dose) or SRT (2 Gy/d, uninterrupted delivery) in combination with concurrent 2 mg/kg CDDP 3 times per week in the final 2 weeks of radiation therapy. Treatment-induced growth delays were defined from twice-weekly tumor volume measurements. Tumor hypoxia was assessed by (18)F-fluoromisonidazole positron emission tomography imaging, and calculated maximum standardized uptake values compared with tumor histology. Tumor vessel density and hypoxia were measured by quantitative immunohistochemistry. Normal tissues effects were evaluated in gut and skin. RESULTS Untreated tumors grew to 1000 mm(3) in 25.4 days (±1.2), compared with delays of 62.3 days (±3.5) for SRT + CDDP and 80.2 days (±5.0) for PRT + CDDP. Time to reach 2× pretreatment volume ranged from 8.2 days (±1.8) for untreated tumors to 67.1 days (±4.7) after PRT + CDDP. Significant differences in tumor growth delay were observed for SRT versus SRT + CDDP (P=.04), PRT versus PRT + CDDP (P=.035), and SRT + CDDP versus PRT + CDDP (P=.033), and for survival between PRT versus PRT + CDDP (P=.017) and SRT + CDDP versus PRT + CDDP (P=.008). Differences in tumor hypoxia were evident by (18)F-fluoromisonidazole positron emission tomography imaging between SRT and PRT (P=.025), although not with concurrent CDDP. Tumor vessel density differed between SRT + CDDP and PRT + CDDP (P=.011). No differences in normal tissue parameters were seen. CONCLUSIONS Concurrent CDDP was more effective in combination PRT than SRT at restricting tumor growth. Significant differences in tumor vascular density were evident between PRT and SRT, suggesting a preservation of vascular network with PRT.
Collapse
Affiliation(s)
- Kurt Meyer
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan
| | - Sarah A Krueger
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan
| | - Jonathan L Kane
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan
| | - Thomas G Wilson
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan
| | - Alaa Hanna
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan
| | - Mohamad Dabjan
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan
| | - Katie M Hege
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan
| | - George D Wilson
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan
| | - Inga Grills
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan
| | - Brian Marples
- Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan.
| |
Collapse
|
40
|
Burbano M, Wilson TG, Valderrama P, Blansett J, Wadhwani CPK, Choudhary PK, Rodriguez LC, Rodrigues DC. Characterization of Cement Particles Found in Peri-implantitis-Affected Human Biopsy Specimens. Int J Oral Maxillofac Implants 2016; 30:1168-73. [PMID: 26394356 DOI: 10.11607/jomi.4074] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
PURPOSE Peri-implantitis is a disease characterized by soft tissue inflammation and continued loss of supporting bone, which can result in implant failure. Peri-implantitis is a multifactorial disease, and one of its triggering factors may be the presence of excess cement in the soft tissues surrounding an implant. This descriptive study evaluated the composition of foreign particles from 36 human biopsy specimens with 19 specimens selected for analysis. The biopsy specimens were obtained from soft tissues affected by peri-implantitis around cement-retained implant crowns and compared with the elemental composition of commercial luting cement. MATERIALS AND METHODS Nineteen biopsy specimens were chosen for the comparison, and five test cements (TempBond, Telio, Premier Implant Cement, Intermediate Restorative Material, and Relyx) were analyzed using scanning electron microscopy equipped with energy dispersive x-ray spectroscopy. This enabled the identification of the chemical composition of foreign particles embedded in the tissue specimens and the composition of the five cements. Statistical analysis was conducted using classification trees to pair the particles present in each specimen with the known cements. RESULTS The particles in each biopsy specimen could be associated with one of the commercial cements with a level of probability ranging between .79 and 1. TempBond particles were found in one biopsy specimen, Telio particles in seven, Premier Implant Cement particles in four, Relyx particles in four, and Intermediate Restorative Material particles in three. CONCLUSION Particles found in human soft tissue biopsy specimens around implants affected by peri-implant disease were associated with five commercially available dental cements.
Collapse
|
41
|
Wilson TG, Valderrama P, Burbano M, Blansett J, Levine R, Kessler H, Rodrigues DC. Foreign bodies associated with peri-implantitis human biopsies. J Periodontol 2016; 86:9-15. [PMID: 25224174 DOI: 10.1902/jop.2014.140363] [Citation(s) in RCA: 123] [Impact Index Per Article: 15.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
BACKGROUND Peri-implantitis is an inflammatory condition that can lead to implant loss. The aim of this descriptive retrospective study is to describe the histopathologic findings in soft tissue biopsies of implants with peri-implantitis. METHODS Thirty-six human peri-implantitis biopsies were analyzed using light microscopy (LM) and scanning electron microscopy (SEM). The composition of foreign materials found in the tissues was assessed using an energy dispersive x-ray spectrometer. RESULTS At the LM level, the inflammatory lesion of peri-implantitis was in most cases a mixture of subacute and chronic inflammation dominated by plasma cells. At the SEM level, radiopaque foreign bodies were identified in 34 of the 36 biopsies. The predominant foreign bodies found were titanium and dental cement. These foreign materials were surrounded by inflammatory cells. CONCLUSIONS At present, the exact mechanism for introduction of these materials and their role in peri-implantitis is unknown. Further research is warranted to determine their etiology and potential role in pathogenesis.
Collapse
|
42
|
Wilson TG, Iyengar AJ, Winlaw DS, Weintraub RG, Wheaton GR, Gentles TL, Ayer J, Grigg LE, Justo RN, Radford DJ, Bullock A, Celermajer DS, Dalziel K, Schilling C, d'Udekem Y. Use of ACE inhibitors in Fontan: Rational or irrational? Int J Cardiol 2016; 210:95-9. [PMID: 26938683 DOI: 10.1016/j.ijcard.2016.02.089] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/12/2015] [Revised: 02/11/2016] [Accepted: 02/14/2016] [Indexed: 12/01/2022]
Abstract
BACKGROUND Despite a lack of evidence supporting the use of angiotensin-converting enzyme (ACE) inhibitors in patients with a Fontan circulation, their use is frequent. We decided to identify the rationale for ACE inhibitor therapy in patients within the Australia and New Zealand Fontan Registry. METHODS All patients in the Registry taking an ACE inhibitor at last follow up were identified, and a review of medical records was undertaken to determine the rationale for treatment initiation and reasons for treatment continuation or dose increase. RESULTS In 2015, 36% of the surviving patients in the Registry (462/1268) were taking an ACE inhibitor. Indications for initiation of therapy were ventricular systolic or diastolic dysfunction (29%), atrioventricular valve regurgitation (19%), preservation of normal ventricular function (7%), prolonged effusions at Fontan (6%), hypertension (6%), other (6%) and unknown (2%). No indication was stated in the remaining patients (25%). Those with hypoplastic left heart syndrome were more likely to be on an ACE inhibitor than those with an alternative primary morphology (70% vs 32%; p<0.001). Only 36% of the patients treated with an ACE inhibitor at last follow up (166/462) had an indication that would generally justify treatment in a two-ventricle circulation. CONCLUSION It is likely that the use of ACE inhibitors in patients with a Fontan circulation is excessive within our region. The coordination of prospective, multicentre studies and initiatives such as the Australia and New Zealand Fontan Registry will facilitate further investigations to guide treatment decisions in the growing Fontan population.
Collapse
Affiliation(s)
- Thomas G Wilson
- Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Australia; Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Victoria, Australia
| | - Ajay J Iyengar
- Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Australia; Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Victoria, Australia
| | - David S Winlaw
- The Heart Centre for Children, The Children's Hospital at Westmead, Sydney, Australia; Department of Paediatrics, University of Sydney, Sydney, Australia
| | - Robert G Weintraub
- Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Australia; Department of Cardiology, Royal Children's Hospital, Melbourne, Australia
| | - Gavin R Wheaton
- Department of Cardiology, Women's and Children's Hospital, Adelaide, Australia
| | - Thomas L Gentles
- Greenlane Paediatric and Congenital Cardiac Service, Starship Children's Hospital, Auckland, New Zealand
| | - Julian Ayer
- The Heart Centre for Children, The Children's Hospital at Westmead, Sydney, Australia; Department of Paediatrics, University of Sydney, Sydney, Australia
| | - Leeanne E Grigg
- Department of Cardiology, The Royal Melbourne Hospital, Melbourne, Australia
| | - Robert N Justo
- Queensland Paediatric Cardiac Service, Lady Cilento Children's Hospital, Brisbane, Queensland, Australia
| | - Dorothy J Radford
- Adult Congenital Heart Unit, The Prince Charles Hospital, Brisbane, Australia; Faculty of Medicine, University of Queensland, Brisbane, Victoria, Australia
| | - Andrew Bullock
- Children's Cardiac Centre, Princess Margaret Hospital for Children, Perth, Australia
| | - David S Celermajer
- Department of Paediatrics, University of Sydney, Sydney, Australia; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia
| | - Kim Dalziel
- Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia
| | - Chris Schilling
- Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia
| | - Yves d'Udekem
- Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Australia; Heart Research Group, Murdoch Childrens Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Victoria, Australia.
| | | |
Collapse
|
43
|
Sridhar S, Wilson TG, Valderrama P, Watkins-Curry P, Chan JY, Rodrigues DC. In Vitro Evaluation of Titanium Exfoliation During Simulated Surgical Insertion of Dental Implants. J ORAL IMPLANTOL 2016; 42:34-40. [DOI: 10.1563/aaid-joi-d-14-00230] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Dissolution of titanium wear particles in the oral environment, and their accumulation in the surrounding tissues have been associated with failure of dental implants (DI). The goal of this study is to investigate the effect of mechanical forces involved in surgical insertion of DI on surface wear and metal particle generation. It was hypothesized that mechanical factors associated with implant placement can lead to the generation of titanium particles in the oral environment. The testing methodology for surface evaluation employed simulated surgical insertion, followed by removal of DI in different densities of simulated bone material. Torsional forces were monitored for the insertion and removal of DI. The surface of the simulated bone materials was inspected with optical microscopy to detect traces of metallic particles that may have been generated during the procedure. Further characterization of the composition of powders collected from osteotomy cavities was conducted with powder X-ray diffraction. The results showed that the different densities of simulated bone material affected the torsional forces associated with implant insertion. However, the mechanical factors involved in the implant insertion/removal procedure did not generate wear particles, as confirmed by powder X-ray experiments.
Collapse
Affiliation(s)
| | | | | | | | - Julia Y. Chan
- Department of Chemistry, University of Texas at Dallas, Richardson, Texas
| | | |
Collapse
|
44
|
Rodrigues DC, Sridhar S, Gindri IM, Siddiqui DA, Valderrama P, Wilson TG, Chung KH, Wadhwani C. Spectroscopic and microscopic investigation of the effects of bacteria on dental implant surfaces. RSC Adv 2016. [DOI: 10.1039/c6ra07760a] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Abstract
The surface morphology and chemical composition of commercially pure titanium dental implants and healing abutments exposed in vitro or in vivo to oral bacteria were studied.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Kwok-Hung Chung
- Department of Restorative Dentistry
- University of Washington
- Seattle
- USA
| | - Chandur Wadhwani
- Department of Restorative Dentistry
- University of Washington
- Seattle
- USA
| |
Collapse
|
45
|
Sridhar S, Wilson TG, Palmer KL, Valderrama P, Mathew MT, Prasad S, Jacobs M, Gindri IM, Rodrigues DC. In Vitro Investigation of the Effect of Oral Bacteria in the Surface Oxidation of Dental Implants. Clin Implant Dent Relat Res 2015; 17 Suppl 2:e562-75. [DOI: 10.1111/cid.12285] [Citation(s) in RCA: 49] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
| | | | - Kelli L. Palmer
- Department of Molecular and Cell Biology; University of Texas at Dallas; Richardson TX USA
| | | | - Mathew T. Mathew
- Section of Tribology; Department of Orthopedic Surgery; Rush University Medical Center; Chicago IL USA
| | - Shalini Prasad
- Department of Bioengineering; University of Texas at Dallas; Richardson TX USA
| | - Michael Jacobs
- Department of Bioengineering; University of Texas at Dallas; Richardson TX USA
| | - Izabelle M. Gindri
- Department of Bioengineering; University of Texas at Dallas; Richardson TX USA
| | | |
Collapse
|
46
|
Wheelis SE, Gindri IM, Valderrama P, Wilson TG, Huang J, Rodrigues DC. Effects of decontamination solutions on the surface of titanium: investigation of surface morphology, composition, and roughness. Clin Oral Implants Res 2015; 27:329-40. [DOI: 10.1111/clr.12545] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/04/2014] [Indexed: 11/27/2022]
Affiliation(s)
- Sutton E. Wheelis
- Department of Bioengineering; University of Texas at Dallas; Richardson TX USA
| | - Izabelle M. Gindri
- Department of Bioengineering; University of Texas at Dallas; Richardson TX USA
| | | | | | | | | |
Collapse
|
47
|
Smolilo D, Bhandari M, Wilson TG, Brooke-Smith M, Watson DI. Bouveret's syndrome: gastric outlet obstruction caused by a gallstone. ANZ J Surg 2014; 83:996-7. [PMID: 24289055 DOI: 10.1111/ans.12227] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- David Smolilo
- Flinders University Department of Surgery, Flinders Medical Centre, Bedford Park, South Australia, Australia
| | | | | | | | | |
Collapse
|
48
|
McGuire MK, Wilson TG. Commentary: From Normal Scientific Progress to Game Changers: The Impact on Periodontal Clinical Practice. J Periodontol 2014; 85:1001-5. [DOI: 10.1902/jop.2014.140220] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
49
|
Valderrama P, Blansett JA, Gonzalez MG, Cantu MG, Wilson TG. Detoxification of Implant Surfaces Affected by Peri-Implant Disease: An Overview of Non-surgical Methods. Open Dent J 2014; 8:77-84. [PMID: 24894571 PMCID: PMC4040927 DOI: 10.2174/1874210601408010077] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2014] [Revised: 02/05/2014] [Accepted: 02/12/2014] [Indexed: 11/22/2022] Open
Abstract
Objective: The aim of this review is to summarize the findings of studies that have evaluated non-surgical approaches for detoxification of implant body surfaces in vitro and in vivo, and to evaluate clinical trials on the use of these methodologies for treating peri-implant disease. Materials and methods: A literature search was conducted using MEDLINE (Pubmed) from 1966 to 2013. In vitro and in vivo studies as well as clinical trials on non-surgical therapy were evaluated. The outcome variables were the ability of the therapeutic method to eliminate the biofilm and endotoxins from the implant surface, the changes in clinical parameters including probing depth, clinical attachment levels, bleeding on probing; radiographic bone fill and histological re-osseointegration. Results: From 134 articles found 35 were analyzed. The findings, advantages and disadvantages of using lasers as well as mechanical and chemical methods are discussed. Most of the in vivo and human studies used combination therapies which makes determining the efficacy of one specific method difficult. Most human studies are case series with short term longitudinal analysis without survival or failure reports. Conclusion: Complete elimination of the biofilms is difficult to achieve using these approaches. All therapies induce changes of the chemical and physical properties of the implant surface. Re-osseointegration may be difficult to achieve if not impossible without surgical access to ensure thorough debridement of the defect and detoxification of the implant surface. Combination protocols for non-surgical treatment of peri-implantitis in humans have shown some positive clinical results but long-term evaluation to evaluate the validity and reliability of the techniques is needed.
Collapse
Affiliation(s)
- Pilar Valderrama
- Department of Periodontics, Texas A & M University, Baylor College of Dentistry, Dallas, Texas 3302 Gaston Avenue, Dallas Texas 75246
| | - Jonathan A Blansett
- Department of Periodontics, Texas A & M University, Baylor College of Dentistry, Dallas, Texas 3302 Gaston Avenue, Dallas Texas 75246
| | - Mayra G Gonzalez
- Universidad de Panama, Facultad De, Odontologia Estafeta Universitaria Apartado 3366, Panama City, Panama, 3366
| | - Myrna G Cantu
- Universidad Autonoma de Nuevo Leon, Dr. Eduardo Aguirre Pequeno Street, Mitras Centro Monterrey, Mexico 64460
| | - Thomas G Wilson
- Private Practice of Periodontics, 5465 Blair Rd, Ste 200, Dallas Texas 75231
| |
Collapse
|
50
|
Due SL, Wilson TG, Chung A, Chen JWC. Endoscopic cyst-gastrostomy for pancreatic pseudocysts: refining the indications. ANZ J Surg 2014; 86:399-402. [PMID: 24801660 DOI: 10.1111/ans.12648] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/19/2014] [Indexed: 12/15/2022]
Abstract
BACKGROUND Pseudocysts are a common consequence of acute pancreatitis and require intervention if symptomatic. Endoscopic management is emerging as a safe and effective alternative to surgery, although its use is not yet widespread. METHODS We describe our experience of 10 consecutive unselected patients who underwent endoscopic ultrasound-guided cyst-gastrostomy and stent insertion at a tertiary referral centre. Technical aspects of the procedure are detailed with accompanying photographs. RESULTS Six patients made an uneventful recovery. Four patients developed complications, of which one was successfully salvaged by endoscopy and three required surgery. CONCLUSION We discuss technical and patient factors which may have contributed to these complications in the context of current literature, and in particular, found that the presence of necrosis was associated with higher morbidity, both in our series and in others. In our experience, endoscopic ultrasound-guided cyst-gastrostomy is best employed in simple, mature pseudocysts without necrotic debris, and we recommend this procedure only after a detailed assessment of the pseudocyst in a specialist hepatobiliary unit.
Collapse
Affiliation(s)
- Steven L Due
- Department of Hepatobiliary Surgery, Flinders Medical Centre, Adelaide, South Australia, Australia
| | - Thomas G Wilson
- Department of Hepatobiliary Surgery, Flinders Medical Centre, Adelaide, South Australia, Australia
| | - Adrian Chung
- Department of Gastroenterology, Flinders Medical Centre, Adelaide, South Australia, Australia
| | - John W C Chen
- Department of Hepatobiliary Surgery, Flinders Medical Centre, Adelaide, South Australia, Australia
| |
Collapse
|